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Advances in microbial genetics have allowed discovery and assignment of function 
for many genes.  High-throughput transcription analysis can be conducted for 
foodborne pathogens to give insight into mechanisms of adaptation and survival in 
adverse conditions.  With heightened knowledge of gene expression in these conditions, 
steps can be taken to counteract adaptive mechanisms and inhibit growth or survival of 
foodborne pathogens.   
Sodium benzoate is a food antimicrobial that is commonly used in beverages and 
fruit juices.  A study was conducted to determine the gene expression of Escherichia coli 
O157:H7 when exposed to sodium benzoate. 
First, a qualitative study to determine transcription of marA, stx1, and eaeA was 
undertaken using real-time reverse transcriptase polymerase chain reaction (rt-RT-PCR).  
Expression of the mar operon causes increased antimicrobial resistance in bacterial 
pathogens. Shiga toxin 1 (Stx1) is a well described verotoxin produced by 
enterohemorrhagic E. coli (EHEC), and EaeA, or intimin, helps establish E. coli O157:H7 
in the intestinal tract.  For marA and stx1, rt-RT-PCR products were detected at a 1-log 
greater dilution in sodium benzoate treated cells, indicating a greater level of 
transcription in these cells.   
Next, a microarray study was conducted to determine transcription of E. coli 
O157:H7 when exposed to 0.5% sodium benzoate.  Results indicate that the phosphate 
specific transport (Pst) system was rapidly (within 5 min) up-regulated in response to 
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sodium benzoate.  This system is essential for supplying phosphate used in synthesizing 
compounds such as ATP, phospholipids, and proteins.  Research with Mycobacterium 
smegmatis also shows that this system can serve as an efflux pump.   
The urease operon was also shown to be up-regulated in E. coli O157:H7 after 60 
min of exposure to sodium benzoate.  Urease catalyzes the hydrolysis of urea to 
ammonia and carbon dioxide, and is one mechanism by which microorganisms survive 
in acidic environments. In this study, exposure of E. coli O157:H7 to sodium benzoate at 
neutral pH showed increase in transcription of the entire urease operon.   
These data indicate that stx1 and marA genes as well as the Pst system and urease 
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Escherichia coli O157:H7 
E. coli O157:H7 is a member of the enterohemorrhagic E. coli (EHEC) and causes 
hemorrhagic colitis in humans. The symptoms of an E. coli O157:H7 infection generally 
include severe abdominal cramps and diarrhea (often times bloody), which can lead to 
death. In children under the age of five, infection can lead to a complication known as 
hemolytic uremic syndrome (HUS), resulting in red blood cell destruction, renal failure, 
and central nervous system complications (99).  E. coli O157:H7 can cause disease at a 
low infectious dose (10 - 100 cells) (86). This can be attributed to the tolerance of this 
bacterium to low pH, which allows passage through the stomach and colonization in the 
intestinal tract (86).  E. coli O157:H7 has been linked as the causative agent in outbreaks 
associated with unpasteurized apple and orange juice, and experimental data 
demonstrate the tolerance of E. coli O157:H7 to acidic environments (15, 24, 88, 112).     
While it is very hard to quantify the impact foodborne illnesses have in the United 
States, it has been estimated that foodborne disease causes 76 million illnesses annually 
and approximately 5,000 fatalities (83).  There were 16,614 laboratory-confirmed cases 
of foodborne illness from FoodNet participants in 2005 (~15% of the United States 
population), and E. coli O157:H7 was the causative agent in 2.8% of these cases (8). The 
CDC estimates that there are 73,000 cases of E. coli O157:H7 annually, leading to an 
estimated 2,100 hospitalizations in the United States (20).  It has been estimated that 
the cost of EHEC infections was $405 million dollars in 2003 (42).   
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 The well-described virulence factors of E. coli O157:H7 include stx1, stx2, and 
eaeA (64, 108).  Shiga toxins are composed of two subunits. The B-subunit binds 
glycolipids in the host, and the A-subunit inhibits protein synthesis via disruption of 
ribosomal RNA (1). Shiga-toxins may cause hemorrhagic colitis, hemolytic uremic 
syndrome (HUS), thrombocytopenia, hemolytic anemia, and renal failure (63). The gene 
eaeA in enterohemorrhagic E. coli produces intimin, a 97-kDa protein that plays a role in 
attachment onto and effacement of microvilli of the small intestine (34, 41, 71, 82, 118).   
Antibiotic resistance patterns of Escherichia coli O157 
The use of antimicrobial agents in food animals can promote antibiotic 
resistance among both target pathogens and normal microflora. This includes 
foodborne pathogens such as E. coli O157:H7, for which cattle are a known reservoir. Of 
236 clinical E. coli  O157:H7 isolates collected in Washington State between 1984-1991, 
5.6% were resistant to streptomycin, sulfisoxazole and tetracycline (65). Among E. coli 
O157:H7 clinical isolates from England and Wales in 1997, 23% were resistant to one 
antibiotic and 2% were resistant to multiple antibiotics (117).  Of the latter, 73% were 
resistant to streptomycin, sulfonamides and tetracyclines and 14% were resistant to 
sulfonamides and tetracyclines. Meng and others (87) noted a similar antibiotic trend 
with resistant strains of E. coli O157:H7 isolated from humans, animals, and foods from 
1984-1993.  Seventy percent of the resistant isolates were resistant to streptomycin, 
tetracycline, and sulfisoxazole (87).  However, 19% of these isolates were resistant to 
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three or more antibiotics (87). The highest rate of antibiotic resistance was seen among 
cattle isolates.   
One hundred and seventy E. coli O157:H7 human isolates were received by the 
Centers for Disease Control and Prevention (CDC) in 2003 (19). Of these, 10.8, 5.1, 3.2, 
and 2.5% of the isolates were resistant to one, two, three and four antibiotics, 
respectively (19). Tetracycline, sulfamethoxazole, and ampicillin were the antibiotics to 
which resistance was the greatest, 5.7, 3.8, and 3.2%, respectively.  E. coli O157:H7 
isolates resistant to at least two Clinical and Laboratory Standards Institute antibiotic 
subclasses increased from 3.8% in 2002 to 5.1% in 2003 (19). Streptomycin, 
sulfisoxazole, and tetracycline are not routinely used to treat diarrhea in North America, 
but selective pressure through the use of antibiotics in animals may select for 
populations of zooinotic pathogens, such as E. coli O157:H7 (65).  The mechanisms 
leading to the observed multiple antibiotic phenotypes in E. coli  O157:H7 are also 
unclear and warrant increased attention. 
Antibiotic therapy of E. coli O157 infections 
Children treated with trimethoprim-sulfamethoxazole at a Montreal pediatric 
hospital from 1989-1990 for E. coli O157:H7 enteritis showed no difference in the length 
of shedding in stool, duration of symptoms, or the occurrence of hemolytic-uremic 
syndrome (HUS) compared to control patients (104). However, patients treated with 
antibiotics in that study were started on an antibiotic regimen after isolation of E. coli 
O157:H7 in their stools, rather late in the course of patient illness. The use of 
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trimethoprim-sulfamethoxazole also did not increase the risk of developing HUS, 
although this was a relatively small population (104).    
 In a prospective cohort study conducted among children infected with E. coli 
O157:H7, nine patients were treated with antibiotics and 62 were not; five children 
from each group developed HUS, 56 and 8%, respectively (P<0.001) (123). Of the five 
children who received antibiotics and developed HUS, two received trimethoprim-
sulfamethoxazole, and three were administered cephalosporins. Other significant 
factors were initial white blood cell count (P=0.02), with risk increasing with white blood 
cell count. Time between the onset of diarrhea to the day on which the initial stool 
culture was obtained also significantly affected outcome (P=0.008); risk of developing 
HUS was inversely proportional to the number of days from onset of diarrhea (123). This 
indicates that a rapid onset of symptoms with increased white blood cell counts gave 
greater risk for HUS regardless of antibiotic treatment. 
 Three strains of E. coli O157:H7 (one producing Stx1, one producing Stx2, and 
one producing Stx1 and Stx2) were studied for Shiga-like toxin (Stx) production when 
exposed to sub-inhibitory levels of antibiotics (53). Trimethoprim and cotrimoxazole 
(trimethoprim and sulfamethoxazole) stimulated Stx production in all three strains. 
However, the 11 other antibiotics tested had varied effects on the release of Stx in the 
three strains studied, and emphasized the differences in virulence factors that can be 
seen among strains of the same pathogen.   
 A survey of physicians who treated the 163 case E. coli O157:H7 outbreak in 
Osaka, Japan reported that 95.9% of the patients treated were given an antimicrobial 
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agent, and fosfomycin was the most commonly prescribed (126). In vitro  assays 
demonstrated a 7-fold increase in Stx1 production with treatment of sub-inhibitory 
concentrations of fosfomycin, while none of the antibiotics tested caused an increase in 
Stx2 production (126). In vivo treatment of mice infected with E. coli O157:H7 with 
ciprofloxacin caused increased Stx2 production that was not observed in mice treated 
with fosfomycin (128). 
 In another murine model, only treatment with  trimethoprim-sulfamethoxazole, 
caused an increase in Stx levels (68). The time of trimethoprim-sulfamethoxazole 
treatment influenced the outcome of mortality. When antibiotic intervention was 
initiated one day post-infection, Stx levels in blood and stool was similar to other 
antibiotic treatments from which no lethality was observed.  However,  when the 
trimethoprim-sulfamethoxazole treatment was started three days post-infection, Stx 
levels in blood and stool were increased above that of the control and resulted in 
increased mortality (68).    
Intrinsic mechanisms of antibiotic/antimicrobial resistance  
Golding and Matthews(51) described an intrinsic mechanism in E. coli O157:H7 that 
results in multiple antibiotic resistance due to a mutation in the multiple antibiotic 
resistance (mar) operon. Of 52 chloramphenicol-resistant E. coli  O157:H7 mutants, half 
were clinically resistant to tetracycline, and resistance at levels below clinical resistance 
to tetracycline, nalidixic acid, and ciprofloxacin was also seen in isolates (51). The mar 
operon has also been shown to contribute to multiple antibiotic resistance in Salmonella 
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Enteritidis isolates resistant to 25 ppm chlorine, 500 ppm acetic acid, 10,000 ppm 
sodium benzoate, or 10,000 ppm sodium nitrite. A single exposure to acetic acid, 
sodium benzoate, or nitrite induced a two- to four-fold increase in resistance to 
tetracycline (103).  Isolates resistant to 25 ppm chlorine showed increased resistance to 
tetracycyline, chloramphenicol, and nalidixic acid, with the greatest resistance to 
tetracycline and chloramphenicol (103). In both studies, susceptibility to the tested 
antibiotics returned to that of the wild-type with complementation of a functional 
marR, a component of the marRAB operon, suggesting that this operon was partly 
responsible for the observed antibiotic resistance (51, 103).    
Multiple antibiotic resistance (mar) operon 
Microorganisms have adapted various intrinsic mechanisms of survival in stressful 
environments.  Multiple antibiotic resistance attributed to chromosomal mutations in 
the mar operon was first described in Escherichia coli K12 when selecting for low levels 
of tetracycline or chloramphenicol resistance (49). The susceptibility of these mutants 
was decreased for the selected agent as well as other structurally unrelated antibiotics 
such as penicillins, cephalosporins, puromycin, nalidixic acid, and rifampin (49, 50).  
When in contact with the selective agent, resistance was induced to high levels; 
however, this resistance was lost when grown in the absence of the inducing agent for 
more than 100 generations (49). Resistances to the selected compounds were greatly 
reduced or reversed by insertion of the composite transposon, Tn5,  into the E. coli 
chromosome near 34 min (1,636.7 kb), designated marA (50). Tn5-inactivated mar 
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mutants produced a truncated message of 0.7 kb, which reverses the Mar phenotype 
(54). When Tn5 was excised from marA::Tn5 tetracycline sensitive mutants, the multiple 
antibiotic resistance phenotype returned at a rate of 10-8 to 10-7 (50). A Mar phenotype 
has been observed in Gram-negative bacteria with clinical resistance to quinolones 
(122).        
 The mar-loci have been sequenced in E. coli K-12 and Samonella enterica serovar 
Typhimurium DT104 and are present in Shigella, Klebsiella, Citrobacter, Enterobacter, 
and Hafnia, indicating that this operon is highly conserved among enteric 
microorganisms (25, 29, 67).  MarA has been found to alter expression of more than 60 
chromosomal genes of E. coli K-12 (13). The expression of MarA altered the 
transcription of outer membrane proteins (e.g., OmpF, OmpX, TolC) and showed 
continued overlap between the marRAB and soxRS regulons that respond to antibiotic 
and oxidative stress.   
Structure of the mar operon 
The chromosomally mediated mar phenotype was found in mutants that 
constitutively express the marRAB operon (26).  The mar locus consists of two 
divergently positioned transcriptional units that flank marO, marC and marRAB  (26, 27). 
The marO gene contains two  promoters for transcription of MarC and MarRAB (PmarI 
and PmarII, respectively) (13). MarC is theorized to be a putative integral inner 
membrane protein with unknown function (13). The proteins produced by the marRAB 
operon are:  MarR, a repressor(26, 111), MarA, an activator that is associated with 
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multiple antibiotic resistance (47, 50), and MarB, for which the function is not yet 
known (80).  
 Increased expression of the marRAB operon will arise from mutations in marO or 
marR or from inactivation of MarR when exposed to inducing agents such as salicylate 
(3, 4, 27). Overexpression of marA from a multicopy plasmid resulted in a Mar 
phenotype in strains where the mar locus was deleted (47). 
marR 
When marRAB is not induced, MarR negatively regulates the transcription of 
MarA by binding to the operator, marO (111). MarR has been found to form oligomers 
at two sites within marO  in vitro (2, 80). Site I begins downstream of the -35 
transcriptional start signal for RNA polymerase (RNAP) binding and includes 4 bp of the -
10 hexamer (80). Site II begins 13 bp away from site I and ends before the transcription 
start signal of marR (80). Site II has about  80% homology with site I, and site I alone was 
able to repress the mar operon (80). Further research demonstrated that MarR was able 
to repress the promoter by a factor of 4.3 with site I in a native form, but marO was 
repressed by a factor of 20 when both sites were in their functional form (81). MarR 
bound to site I could interfere with the binding of RNAP to the -35 and -10 transcription 
start signals, thus blocking transcription of marRAB.  MarR binding at site II may 
interfere with the formation of an open complex necessary for transcription (81).    
The crystalline structure of MarR reveals that it functions as a dimer, and each 
monomer has a region of two -helices and three -sheets giving rise to a winged helix 
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DNA binding domain (2, 5).  Footprinting studies have suggested that MarR is bound to 
DNA as a dimer since about 20 bp in both strands of DNA in sites I and II of marO were 
protected from digestion by DNAse (80).  The 20 bp binding site of marO is centered on 
a palindromic sequence TTGCCnnGGCAA (where n = any nucleotide), and in vitro when 
TTGCC was transversed, all DNA binding ability was lost (81).  When the two winged 
binding domains (Mar-R and Mar-C) were compared among known MarR proteins, Mar-
R was found to be highly conserved while functional regions of Mar-C were not (125).  
These unconserved regions may arise from strain specific differences in marO for which 
the repressor must be able to recognize (125).   
marA 
The accumulation of an activator, e.g. MarA, is the primary factor that controls 
the expression of mar phenotype (13, 54).  Of the > 60 chromosomal genes whose 
expression is altered by MarA, approximately 80% increased in transcription and the 
remainder were down-regulated (13).   MarA is in the AraC/XylS family of transcriptional 
regulators that have a helix-turn-helix DNA binding motif and are positive transcriptional 
regulators (45, 46).  The structurally related transcriptional activators SoxS and RobA are 
also members of the AraC/XylS family and were first associated with response to 
superoxide stress and organic solvents.  MarA and Rob share 41 and 55% sequence 
identity with SoxS, the smallest of the proteins in this trio.  To different extents, all three 
proteins regulate genes in the mar/sox/rob regulons.  The members of this family share 
a conserved region composed of 99 amino acids (carboxy terminus MarA and SoxS; 
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amino terminus Rob) that bind DNA as monomers in the promoter region and stimulate 
RNAP contact and subsequent transcription (39, 46).   
The region of DNA that MarA binds to is a 20 bp degenerate sequence know as a 
‘marbox’ that does not indicate a preference for MarA, SoxS or RobA (77, 78).  The 
consensus sequence defined by Martin and others(77) (AYnGCACnnWnnRYYAAAYn; 
where R = G/A, W = A/T, Y = C/T, and n = any nucleotide) is either found upstream (class 
I) or overlapping (class II) the -35 signal for RNAP (78).  The location and orientation of 
the marbox from the -35 and -10 signals for RNAP has been found to be specific for the 
promoter (77).  The class I promoters (e.g. mar, acrAB, and fpr) interact with the -
carboxy terminal domain (  CDT) of RNAP, and their marbox is located in a reverse or 
backward orientation (60, 61).  In the backward orientation, MarA binds with its amino 
terminus proximal to the RNAP signal(77).  zwf and nfsA are class I promoters that do 
not follow this pattern; their marbox is in a forward orientation and closer to the -35 
RNAP signal (59, 100).  Class II promoters (e.g. fumC, inaA, sodA and micF)  do not 
require interaction with  CDT, and their marbox is in the forward orientation and 
overlaps the -35 RNAP hexamer (78).   
Multiple marboxes have been identified for some promoters (e.g. micF  and  
zwf), that lie farther upstream of the -35 RNAP signal, but most transcriptional 
activation for zwf  and micF is attributed to the marbox located closest to the promoter 
(38, 39, 69).  It has been demonstrated in vitro that SoxS and MarA can utilize the same 
marbox sequence to activate zwf transcription (glucose 6-phosphate dehydrogenase) 
(60).   
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Induction of the mar operon 
Expression of marA can be induced by exposure to low levels of tetracycline, 
chloramphenicol (49), salicylates (27, 109) , organic solvents (11), benzoate (103, 109), 
chlorine, nitrite, acetic acid (103), pine oil (90), bile salts (105), spices, and various food 
extracts (107).  Phenolic compounds, such as salicylate, induce transcription of the mar 
operon by binding to the repressor, MarR (79).  Deoxycholate, a bile salt, has also been 
found to bind to MarR also preventing binding to the mar operator region (105).  Once 
the repressor can no longer bind to the operator region, transcription of marAB is 
induced.      
 Constitutive expression of the marRAB operon may give mutants the ability to 
initially survive treatment with antibiotics and allow low-level resistance to many 
antimicrobials until secondary mutations arise giving increased resistance to a specific 
agent (26).  Bacterial strains expressing a mar phenotype were found to be sensitive to 
household disinfectants containing hydrogen peroxide, hypochlorite, alkyl dimethyl 
benzyl ammonium chloride (a quaternary amine), or chloroxylenol (a phenol) (90).  
Increased levels of MarA, SoxS, or RobA resulted in an increase in resistance to many 
hydrophobic antibiotics, but expression of the mar/sox/rob regulon was not found to 
cause resistance to hydrophilic aminoglycosides (11). 
SoxRS 
The SoxR is constitutively expressed and contains binuclear iron-sulfur clusters (6, 
57, 124).  When the iron-sulfur clusters are in an oxidized state, SoxS expression is 
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dramatically increased compared to when these clusters are in a reduced form (58).  
SoxR binds equally well to the promoter of SoxS in a reduced or oxidized state, and the 
oxidized state is thought to aid in the open-complex formation of RNA polymerase (33). 
Like MarA, SoxS activates transcription of a number of genes in response to 
superoxide and  antibiotic stress (6, 58, 69, 70).  Li and Demple (69) demonstrated that 
purified SoxS bound near the promoter region of genes under control of the soxRS 
regulon (e.g. micF, nfo, zwf, and sodA) and increased the transcription of these genes.  
SoxS was shown to bind in vitro to a region adjacent to or overlapping the -35 RNAP 
signal of zwf, sodA, nfo, micF, and fumC (38). The superoxide generating herbicide, 
paraquat, induced soxS expression and caused transcription of sodA and micF (102).  
Disruption of sodA caused increased sensitivity to cells treated with paraquat (102).     
Rob 
SoxS and MarA are very similar to the amino terminus of the Rob protein that is 
known to bind to the right arm of the origin of replication, oriC (10, 113).  Rob is located 
at 99.8 min on the E. coli K-12 chromosome and also has a helix-turn-helix motif found 
in MarA and SoxS (113).  Unlike MarA and SoxS, Rob is constitutively expressed to fulfill 
an unknown purpose.  Rob has been reported at levels of 5000 and 1000 molecules per 
cell for stationary and log phase cells, respectively (62, 113).   
Overexpression of Rob resulted in increased resistance to multiple antibiotics 
and superoxide generating agents (10).  Rob activated the transcription of zwf, fumC, 
micF, nfo and sodA by binding to the marbox region and interacted with the promoters 
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of the affected genes similarly to SoxS and MarA (61).  Rob had the same affinity for 
binding micF promoter as oriC and bound more weakly to the promoters of sodA, nfo 
and zwf (10). 
Overlaping Regulation by MarA, SoxS and RobA 
Although MarA, SoxS and RobA can regulate the same promoters that respond to 
multiple antibiotic and superoxide resistance, each protein activates promoters to 
different extents.  The marbox is very important in activator discrimination of 
promoters.  Martin and others (78) found that differences in the marboxes versus the 
core promoters were the principal factors involved in activator discrimination.   
Martin and others (78) demonstrated that overproduction of SoxS in marRAB 
and soxRS deleted strains led to greater superoxide resistance than overproduction of 
MarA; however, both MarA and SoxS were equally effective in promoting antibiotic 
resistance.  MarA was also shown to increase transcription of seven proteins that were 
unaffected by SoxS (52).  Levels of organic solvent tolerance were reduced in wild type 
and Mar mutants when only SoxS was present (119).  Overproduction of SoxS causes 
greater superoxide and antibiotic resistance than does overproduction of RobA (10).  
Overexpression of SoxS results in greater transcription of fumC, sodA, and inaA when 
compared to RobA, and RobA does not stimulate transcription of zwf (10).   
When the marbox from the mar promoter was substituted for the native zwf 
marbox, MarA transcriptional activation increased relative to that of SoxS (78).  When 
the micF promoter marbox was replaced for that of fpr, SoxS transcriptional activation 
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was increased compared to that of MarA (78).  The position of the marbox relative to 
the promoter (i.e., class I versus class II) has not been shown to be a discriminating 
factor for activators (78).  Promoter discrimination allows for specialized transcriptional 
activation of MarA, SoxS and RobA.  Minute differences between these activators can 
result in different affinities and interactions with promoter marboxes resulting in varied 
regulation of many genes within the mar/sox/rob regulon. 
Genes induced by Mar, Sox, and Rob  
acrAB 
AcrAB is part of a multi-drug efflux system, AcrAB-TolC.  AcrA is a periplasmic 
lipoprotein that spans the periplasmic space between the inner membrane, where its 
amino terminus is anchored, and outer membrane proteins (48).  AcrA is also a member 
of the membrane-fusion protein (MFP) family (48).  AcrB is a putative pump and a 
member of the resistance-nodulation-division (RND) family (48).   
AcrAB expression is under control of MarA and AcrR (72, 96).  In both wild-type 
and Mar mutants, where the acrAB locus was deleted, hyper-susceptibility to antibiotics 
and organic solvents occurred to the same extent (90, 96, 119).  Active efflux of harmful 
compounds has been shown to be a resistance mechanism that results in multiple 
antibiotic resistance (14).  AcrAB production causes an intrinsic level of resistance that is 




TolC is an outer membrane porin that is part of the AcrAB-TolC efflux system (40).  
TolC has been shown to be positively regulated by MarA, SoxS, and RobA (9, 13).  
Increased resistance to organic solvents has been attributed to increased levels of the 
TolC outer membrane protein and the AcrA inner membrane protein (9).  A defective 
tolC gene results in increased sensitivity to organic solvents, and TolC is required for the 
expression of the Mar phenotype (9, 40).  
micF  
micF encodes an antisense RNA regulator of outer membrane protein F (OmpF), 
which serves as a passage for hydrophilic substances (95).  The mRNA product of micF 
has a long sequence that is complementary to the 5’ end region of ompF mRNA.  OmpF 
and OmpC are the two major outer membrane porins of E. coli K-12 (95).  Limiting OmpF 
has been shown to occur in E. coli K-12 expressing a Mar phenotype, and cells devoid of 
a micF locus were unable to cause a reduction in OmpF (13, 28).  MarA has been shown 
to increase expression of micF, causing a decrease in ompF mRNA that is available to 
undergo translation (13, 28). 
zwf, fumC, and sodA 
Many proteins are involved in protection of the cell from oxidative stress and are 
positively controlled by the mar/sox/rob regulons (60, 61, 69, 93, 102).  zwf (glucose 6-
phosphate dehydrogenase) generates NADPH that supplies reducing capability for 
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antioxidant enzymes (e.g., glutathione reductase and alkylhydroperoxide reductase) (32, 
43).  fumC is heat-stable fumarase that replaces superoxide sensitive fumarases A and B 
that are inactivated by superoxide radicals (32, 43).  sodA (manganese superoxide 
dismutase) scavanges O2
.-  (superoxide) and hydrogen peroxide, thereby retarding 
oxidative damage (32).      
inaA 
InaA is a weak-acid inducible protein, and the membrane-permeant acids that 
induce inaA have the ability to lower the internal pH of the cell or act as uncouplers of 
oxidative phosphorylation (106).  Non-dissociating analogs of benzoate and salicylate 
(benzyl and salicyl alcohol) were unable to induce expression of inaA (120).   inaA maps 
to 48.6 min on the E. coli K-12 chromosome and has been shown to be positively 
regulated by SoxS and MarA (110, 120).  Expression of MarA is responsible for 20-50% of 
the basal expression of inaA, and mar deleted strains contained 30-50% less InaA when 
compared to mar  strains induced with paraquat (110).   
nfsA 
nfsA (formerly mdaA) encodes a major oxygen-insensitive nitroreductase that is a 
flavoprotein in Escherichia coli which catalyzes the reduction of nitroaromatic and 
nitroheterocyclic compounds by the transfer of two electrons from NADPH (100).  nsfA  
has been mapped to 19.2 min on the E. coli K-12 chromosome (127).  nsfA has been 
shown to be expressed under positive regulation of MarA and SoxS (13, 31, 70).  A gene 
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of unknown function, ybjC, is expressed by MarA and SoxS in a similar manner, and 
these two genes may form an operon (13, 31).  The marbox for nfsA is a class I promoter 
in forward orientation (100). 
Escherichia coli O157:H7 Urease Operon 
Escherichia coli O157:H7 is known to produce urea when degrading arginine to 
putrescine (91, 92).  Urease (EC 3.5.1.5) catalyzes the reaction of urea into two 
molecules of ammonia and carbon dioxide (89).  The liberated ammonia results in 
increased pH of the surrounding environment.   Escherichia coli O157:H7 EDL933 
genomic sequence contains an O-island with two urease gene clusters (ureDABCEFG) 
(101).  Urease is composed of three structural proteins, UreA, UreB, and UreC, as well as 
four accessory proteins, UreD, UreE, UreF, and UreG (89).  This enzyme could give 
enterohemorrhagic E. coli (EHEC) the ability to neutralize acidic environments and allow 
for survival in acidic food products as well as support survival in the gastrointestinal 
tract.   
When studying the presence of the urease gene clusters in E. coli O157:H7 
isolates, it was found that among serotype O157:H7 isolates (n= 59), 98% contained all 
genes in the urease operon(44).  In contrast, none of the genes in the urease operon 
were present in sorbitol-fermenting O157:NM (non-motile) isolates (n=82) (44).   
However, among O157:H7 isolates found to have the urease operon, only one was 
found to have urease activity when evaluated with Christensen’s agar or with the API 
20E system; in this isolate, elevated levels of ammonia  were detected (44).  When 
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evaluating nine isolates of serotype O55:H7, from which E. coli O157:H7 has been 
theorized to have diverged, none contained genes in the urease operon (44).   
Similarly, Orth et al. (97) studied the distribution of ureC among 202 EHEC that 
encompassed 61 serotypes.  It was found that all O157:H7 and O157:NM (n=72) that 
displayed the typical non-sorbitol fermenting phenotype possessed the ureC  gene (97).  
However, all sorbitol fermenting  O157:NM isolates (n=8) were negative for ureC (97).  
All isolates containing ureC were also found to contain all genes in the urease operon 
(97).   When the ureC isolates were evaluated for urease production in urease 
degradation broth, only 3.4% showed urease activity (97).  The nucleotide sequence of 
all urease genes present in ten O157:H7 isolates studied were found to have ≥ 99% 
homology (97).  These data indicate that the urease operon was acquired by O157:H7 
relatively recently and possibly through horizontal gene transfer or gene loss since both 
O55:H7 and sorbitol fermenting O157:NM strains lack the urease gene cluster, and 
although many E. coli O157:H7 isolates contain the urease operon, it is not commonly 
expressed under normal culture conditions. 
Nakano et al. (94) examined urease production by E. coli O157:H7 Sakai in 
various culture media, pH, temperatures, and nutrients via ammonia production 
without any success at stimulating urease production.  When further examining 120 
EHEC isolates for urease activity, two isolates were identified as being urease positive 
(94).  All isolates were determined to have a urease operon of similar size (4940 bp), and 
the nucleotide sequence was similar for a urease positive strain compared to the Sakai 
strain except for a slightly longer open reading frame in the ureD gene of the urease 
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positive isolate (94).  It was revealed that the Sakai strain as well as all urease negative 
EHEC isolates examined (n=158) had a premature stop codon for ureD compared to that 
of the urease negative isolate.  When the ureD gene of a urease positive EHEC was 
transformed into the Sakai strain urease production was detected (94).  These data 
indicate that the premature stop codon in UreD plays a role in urease production in 
vitro.   
When attempting to stimulate urease production in E. coli O157:H7 strain 
EDL933, urease could not be detected using Christensen’s agar, enzymatic assays, or 
immunoblotting techniques  targeting  UreC and UreD (56).  However, when non-
pathogenic E. coli DH5  was transformed with the EHEC ure gene cluster, urease was 
detected via enzymatic activity (56).   This demonstrated that the urease genes present 
in the EDL933 strain were functional, but failed to be expressed under multiple culture 
conditions.  It is interesting that the ureD nucleotide sequence in strain EDL933 is 
identical to Sakai (94).  When Nakano et al.(94) transformed the Sakai ureD gene into E. 
coli DH5 , urease was detected.  The authors believe that the amber suppressor 
phenotype of DH5  played a role in read-through of the premature stop codon. Heimer 
et al. (56) determined that a trans-acting factor was inhibiting urease transcription in 
EHEC.  These authors also identified three Fur-like (ferric-uptake regulator) recognition 
sites upstream of ureA and ureD (56).  In this study, urease production was detected in 
two other EHEC strains (IN1 and MO28), and a Δfur background greatly diminished the 
urease activity of these strains (56).  This research indicated that Fur, as well as other 
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unidentified trans-acting factors, plays a role in regulating the expression of urease in 
EHEC.   
Phosphate Specific Transport (Pst) of E. coli 
 The acquisition of phosphorus is essential for bacteria to supply energy and 
synthesize DNA, RNA, lipopolysaccharides, and phospholipids.  Microorganisms must 
transport inorganic phosphorus (Pi) into the cytoplasm in order to survive.  The first step 
in this process for E. coli is to transport organic and inorganic forms of phosphorus 
across the cell wall.  In E. coli there are two common pore-forming proteins, OmpC and 
OmpF.  However, under phosphate limited situations, a third anion binding porin, PhoE, 
is expressed in order to sequester phosphorus into the periplasm (98).   
 The Pst system is in the ATP binding cassette (ABC) superfamily of transporters 
and is one mechanism of transporting Pi across the cell membrane.  This system is 
known to be expressed when Pi concentration is below 0.001 M (116).  This system has a 
high affinity for binding of phosphate and is composed of four proteins, PstS, PstC, PstA, 
and PstB (116).  The gene pstS (formerly phoS) encodes a phosphate binding protein 
that binds Pi in the periplasmic space where it can be transported across the cell 
membrane (84, 85, 121).  PstC and PstA are transmembrane proteins that form a 
passage across the cell membrane (30), while PstB catalyzes the movement of 
phosphorus into the cytoplasm by hydrolysis of ATP (22).   
 PhoR and PhoB regulate the Pho regulon, for which the Pst system is a member.  
PhoR is a transmembrane signal transduction protein that senses low levels of Pi in the 
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periplasm.  PhoR has an extracellular sensory domain and an intracellular signaling 
domain(114).  Under phosphate limited conditions, PhoR undergoes 
autophosphorylation and acts as a histidine kinase that phosphorylates PhoB (75, 76).  
Once PhoB is activated, it will begin to stimulate the Pho regulon by binding to the ‘Pho 
box’ consensus sequence stimulating transcription of pstS  (74, 75).  In addition to 
pstSCAB, PhoB also regulates the expression of PhoA, which is a periplasmic alkaline 
phosphatase that will free Pi from phosphate containing compounds so it is available for 
uptake into the cytoplasm.  PhoU is a 21 KDa cytoplasmic protein that is necessary for 
repression of the Pho regulon (7, 76).  Repression occurs when PhoU acts to promote 
dephosphorylation of PhoB, thus inactivating this protein (114). 
 A role other than phosphate transport has been determined for the Pst system in 
Mycobacterium smegmatis.  A M. smegmatis strain which was resistant to ciprofloxacin 
was found to over-express the Pst operon when grown in sufficient quantities of 
phosphorus (12, 16, 21).   The pstB gene was also shown to have increased amplification 
on the chromosome of the M. smegmatis ciprofloxacin resistant strain(21).  When the 
pstB gene was mutated, the minimum inhibitory concentration of M. smegmatis to 
ciprofloxacin was greatly reduced (12).  It was also demonstrated that the ciprofloxacin 
resistant strain had a much greater efflux of this fluoroquinolone from the cell 
compared to that of the wild type or pstB mutant (12).  The fluoroquinolone resistant 
M. smegmatis strain showed increased phosphate uptake that was diminished along 
with ciprofloxacin resistance when pstB was mutated (16).  These results indicate that 
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the Pst system serves as an efflux mechanism of fluoroquinolone for M. smegmatis in 
addition to the traditional role as a high-affinity transporter of phosphorus.       
Sodium Benzoate 
Sodium benzoate is a food additive commonly used in acidic beverages due to its 
relatively low pKa (4.2) and increased solubility (compared to benzoic acid).  This 
compound is generally recognized as safe and may be added at concentrations up to 
0.1% in foods (21 CFR 184.1733). 
Proposed Mechanisms of Microbial and Fungal Inhibition with Weak Acids 
A general mechanism of inhibition for weak acids starts with diffusion of the 
undissociated compound through the plasma membrane by passive diffusion.  Once 
inside the cell, the higher pH causes dissociation of the acid and lower intracellular pHi 
and inhibition of membrane-bound transport (18).  Eklund (35) determined that uptake 
inhibition contributed to growth inhibition, but did not seem to completely explain this 
phenomenon.  Eklund (37) found that ΔpH (pH difference) was eliminated by sorbic acid 
as well as methyl and butyl paraben, whereas the membrane potential (Δψ) was 
maintained (37).  This indicates more than simple inhibition of the proton motive force, 
since the membrane potential maintained would allow for uptake of essential 
compounds for cellular maintenance.   
 It has been determined that dissociated weak acids also contribute slightly to 
growth inhibition, which cannot be explained by the effects of pHi (36).  Sorbic acid, 
24 
 
sorbic alcohol, and sorbic aldehyde have been found to cause similar levels of inhibition, 
demonstrating a mechanism of inhibition other than a weak acid effect (115).      
 Bracey et al. (17) found that pHi was not altered in Saccharomyces cerevisiae 
exposed to sorbic acid.  However, a higher ADP/ATP ratio was found, indicating that the 
cell was expending energy to maintain pHi (17), and this expenditure of ATP was 
theorized to decrease cellular growth.  Membrane disruption has also been attributed 
as a mechanism of inhibition by weak acids (17, 115).   Krebs and et al. (66) observed a 
reduction in phosphofructokinase activity in Saccharomyces cerevisiae when exposed to 
benzoate (66).  The disruption of glycolysis was thought to be caused by a decrease in 
pHi that decreased the enzymatic activity of phosphofructokinase.Nitrogen starvation 
and benzoic acid treatment inhibit growth of Saccharomyces cerevisiae.  However, when 
used in combination, they are cytocidal (55).  It was found that benzoic acid inhibited 
the break-down of cytosolic compounds to form amino acids and nucleotides necessary 
for growth and survival (55).    
 Some microorganisms contain pathways to degrade weak acids.  Benzoate is 
degraded in microorganisms via the -ketoadipate pathway resulting in acyl CoA and 
succinic acid (23).  These degradation pathways serve as innate responses to weak acid 
resistance.  
 The following chapters of this dissertation will discuss the transcriptional 
response of Escherichia coli O157:H7 when exposed to sodium benzoate.  This will help 
determine some of the primary mechanisms by which E. coli responds and survives this 
stressful environment.  It is essential to identify and understand these mechanisms, so 
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that methods can be developed by the food industry to inhibit or control the survival of 
this pathogen in foods. 
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Transcription Analysis of stx1, marA, and eaeA Genes in 














 Expression of the multiple antibiotic resistance (mar) operon causes increased 
antimicrobial resistance in bacterial pathogens. The activator of this operon, MarA, can 
alter expression of >60 genes in E. coli K12. However, data are lacking concerning the 
expression of virulence and resistance genes when foodborne pathogens are exposed to 
antimicrobial agents. This study was conducted to determine transcription of marA (mar 
activator), stx1A (Shiga toxin 1), and eaeA (intimin) genes of E. coli O157:H7 EDL933 as 
affected by sodium benzoate. E. coli O157:H7 was grown in Luria-Bertani broth (LB) 
containing 0 (control) and 1% sodium benzoate at 37°C for 24 h, and total RNA was 
extracted. Primers were designed for hemX (209 bp; housekeeping gene), marA (261 
bp), and eaeA (223 bp) genes; previously reported primers were used for stx1. Ten-fold 
dilutions of RNA were used in a real-time one-step reverse-transcriptase polymerase 
chain reaction (rt-RT-PCR) to determine transcription levels. All experiments were 
conducted in triplicate and product detection was validated by gel electrophoresis. For 
marA and stx1, rt-RT-PCR products were detected at a 1-log greater dilution in sodium 
benzoate treated cells than control cells, although cell numbers for each were similar 
(7.28 and 7.57 log CFU/ml, respectively). This indicates a greater (albeit slight) level of 
their transcription in the treated as compared to control cells. No difference in 
expression in the eaeA gene was observed. HemX is a putative uroporphyrinogen III 
methylase. The hemX gene had the same level of expression in control and treated cells, 
validating hemX as an appropriate housekeeping marker. These data indicate that stx1 
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and marA genes could play a role in pathogen virulence and survival when treated with 
sodium benzoate, while eaeA expression is not altered.  Understanding adaptations of E. 
coli O157:H7 during antimicrobial exposure is essential to better understand and 




The impact of foodborne illnesses are very hard to quantify. However, it has 
been estimated that foodborne diseases cause 76 million illnesses and 325,000 
hospitalizations in the U.S. annually (29).  Escherichia coli O157:H7 alone causes an 
estimated 73,000 cases of foodborne illness annually with a 0.29% hospitalization rate 
(29). The Foodborne Diseases Active Surveillance Network (FoodNet) of the Centers for 
Disease Control and Prevention (CDC) Emerging Infections Program collects data from 
10 states, which represents approximately 15% of the United States population.  In 
2005, 16,614 cases of foodborne illness were reported, and E. coli O157 was linked as 
the causative agent in 2.8% of these cases (41).   
Understanding survival of E. coli O157:H7 in the environment during exposure to 
stressful conditions is necessary in order to apply efficacious decontamination and 
control strategies. Microorganisms manifest various intrinsic mechanisms for survival in 
stressful environments. Multiple antibiotic resistance attributed to chromosomal 
mutations in the mar operon (multiple antibiotic resistance) was first described in 
Escherichia coli K12 when selecting for low levels of tetracycline or chloramphenicol 
resistance (17). The mar-loci are present in E. coli K-12,  Salmonella, Shigella, Klebsiella, 
Citrobacter, Enterobacter, and Hafnia, indicating that this operon is highly conserved 
among enteric microorganisms (7, 10, 24).   
The chromosomally mediated mar phenotype was found in mutants that 
constitutively express the marRAB operon (8). The mar locus consists of two divergently 
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positioned transcriptional units that flank marO: marC and marRAB.  The proteins 
produced by the marRAB operon are: MarR, a repressor (8, 38); MarA, an activator that 
is associated with multiple antibiotic resistance (16, 18); and MarB, for which the 
function is not yet known (27).   
 The accumulation of  MarA is the primary factor that controls expression of the 
mar phenotype (3, 19). MarA has been found to alter expression of more than 60 
chromosomal genes; approximately 80% of these increased in transcription, and the 
remainder were down-regulated in E. coli K-12 (3). The expression of MarA altered the 
transcription of outer membrane proteins (e.g., OmpF, OmpX, OmpC) and increased 
expression of multi-drug efflux systems. MarA transcriptional regulator has a region 
composed of 99 amino acids that bind DNA as monomers in the promoter region and 
stimulate RNA polymerase contact and subsequent transcription (13, 15). 
Constitutive expression of the marRAB operon may give microorganisms the 
ability to initially survive treatment with antibiotics and allow low-level resistance to 
many antimicrobials until secondary mutations arise giving increased resistance to a 
specific agent (8).  Also, the increase in ability of the organism to survive may increase 
its virulence and/or vice versa.  
The well-described virulence factors of E. coli O157:H7 include stx1 and eaeA 
(22, 36).  Shiga toxin, stx1, is composed of two subunits. The B-subunit binds glycolipids 
in the host, and the A-subunit inhibits protein synthesis via disruption of ribosomal RNA 
(1). Shiga-toxins may cause hemorrhagic colitis, hemolytic uremic syndrome (HUS), 
thrombocytopenia, hemolytic anemia, and renal failure (21). The gene eaeA in 
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enterohemorrhagic E. coli produces intimin, a 97-kDa protein that plays a role in 
attachment onto and effacement of microvilli of the intestine (11, 14, 26, 28, 40).  
Sodium benzoate is a food additive commonly used in acidic beverages due to its 
relatively low pka (4.2) and increased solubility (compared to benzoic acid).  This 
compound is generally recognized as safe and may be added at concentrations up to 
0.1% in foods (21CFR184.1733). A general mechanism of microbial inhibition for weak-
acids, such as benzoic acid, starts with passive diffusion of the undissociated compound 
through the plasma membrane. Once inside the cell, the  neutral internal pH causes 
dissociation of the acid, reduction in intracellular pHi, and inhibition of membrane-
bound transport (5). E. coli O157:H7 has been linked as the causative agent in outbreaks 
associated with unpasteurized apple and orange juice, and experimental data 
demonstrate the tolerance of E. coli O157:H7 to acidic environments (4, 6, 30, 39).     
Expression of the marA gene and the transcriptional response of two virulence 
factors, stx1 and eaeA, were investigated to determine the effects of sodium benzoate 
exposure. It was the goal of this research to compare expression of stx1, eaeA, and 
marA genes of control E. coli O157:H7 (untreated) and E. coli O157:H7 strain EDL933 
exposed to 1% sodium benzoate.     
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Materials and Methods 
Growth of Escherichia coli O157:H7 
Escherichia coli O157:H7 strain EDL 933 (genome fully sequenced), obtained 
from the National Food Safety and Toxicology Center at Michigan State University, was 
used for this study. Cultures were grown in Luria-Bertani broth (LB; Difco, Becton 
Dickinson Microbiology Systems; Sparks, MD) containing 0 (control) or 1% sodium 
benzoate (Fisher Scientific; Fair Lawn, NJ) at 37˚C for 24 h,  and transferred a minimum 
of three successive times at 24-h intervals before use. Cell counts were determined by 
serial dilutions of the overnight culture and plating on LB agar. 
RNA Extraction 
 The RNeasy® mini kit (Qiagen; Valencia, CA) procedure was used to extract total 
RNA. Briefly, 1 ml of a 24-h culture was combined with 2 ml RNAprotect® bacteria 
reagent (Qiagen; Valencia, CA) and incubated for 5 min prior to centrifugation at 10,000 
x g (4˚C) for 10 min. The cell pellet was combined with lysozyme (3 mg/ml; Sigma 
Aldrich; St. Louis, MO) in 100 µl 1x Tris-EDTA buffer (TE; Promega; Madison, WI) and 
incubated for 5 min with frequent agitation. The remainder of the extraction steps were 
followed according to the manufacturer’s instructions and yielded 30 µl total RNA in 
DNase-RNase free water that was stored at -80˚C. RNA quantity (A260) and purity 
(A260/A280; A260/A230) were determined using a Nanodrop ND-1000 spectrophotometer 
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(Nanodrop Technologies; Wilmington, DE, USA). Extracted RNA from all samples was 
diluted as appropriate to obtain equal concentrations for each treatment (35 ng/µl). 
Nucleic Acid Amplification 
Real-time one-step reverse-transcriptase PCR (rt-RT-PCR) was performed on 
serially-diluted RNA extracts. SuperScript™ III Platinum® SYBR® green one-step rt-RT-PCR 
kit reagents (Invitrogen; Carlsbad, CA) were utilized in 50 µl reactions (5 µl serially-
diluted RNA, 25 µl SYBR® green reaction mix, 2 µl BSA, and 1 µl SuperScript™ III reverse 
transcriptase/Platinum® Taq Mix, 0.05 µg forward and reverse primers for the target 
gene, and the remainder RNase-DNAse free water). Primer sequences (Table 2.1) were 
developed for marA, eaeA, and hemX using Beacon Designer 4.0 software (Premier 
Biosoft International; Palo Alto, CA), and previously reported primers were utilized for 
stx1 (20). All tables and figures are found in an appendix located at the end of the 
chapter.  A Bio-Rad iCycler iQ™ multi-color real-time PCR detection system was used to 
conduct rt-RT-PCR using the following parameters: 1) conversion of mRNA to cDNA, 35 
min at 50˚C; 2) denature reverse-transcriptase, 2 min at 94˚C; 3) denature template, 45 
sec at 94˚C; annealing of primers, 45 sec with appropriate temperature (Table 2.1); and 
extension with Taq polymerase, 45 sec at 72˚C; repeated 50 times; 4) final extension, 7 
min at 72˚C. All reactions were verified by gel electrophoresis, and all RT-PCR 
experiments were conducted in triplicate for each RNA sample. 
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Results and Discussion 
 Transcription of marA and stx1 was 1-log greater in E. coli O157:H7 grown in the 
presence of 1% sodium benzoate as compared with the control, although cell numbers 
for each were similar when plated on LB agar (7.28 and 7.57 log CFU/ml, respectively). 
Table 2.2 lists the average cycle threshold (Ct) value and the limit of detection for each 
target transcript under treatment and control conditions. As an example of rt-RT-PCR 
results, output for marA is shown in Figure 2.1. Melt temperature analysis of rt-RT-PCR 
revealed that a single, specific product was produced for each target gene transcript 
(Figure 2.2). Gel electrophoresis confirmed rt-RT-PCR results revealing amplicons of the 
appropriate size, where marA and stx1 products were visualized at a 1-log higher 
dilution in cells grown in 1% sodium benzoate (Figure 2.3) than in control. Both control 
and treated cells had similar transcription levels for eaeA.  Under these conditions, 
hemX was validated as an appropriate housekeeping gene as it was expressed at similar 
levels in both treatments. It was equally important to design primers for the 
housekeeping gene that could be utilized at multiple annealing temperatures.  Each 
primer set was optimized for the desired gene target as could be determined from the 
melt temperature analysis showing single peaks (Figure 2.2).  
 Expression of marA can be induced by exposure to benzoate (33, 37), chlorine, 
nitrite, acetic acid (33), pine oil (31), bile salts (34), spices and various food extracts (35), 
low levels of tetracycline and chloramphenicol (17), salicylates (9, 37), and organic 
solvents (2). Salicylic acid and deoxycholate have been shown to induce transcription of 
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the mar operon by binding to the repressor, MarR (27, 34). Once the repressor can no 
longer bind to the operator region, transcription of marAB is induced. This mechanism 
may play a role in the observed increase in transcription of marA when exposed to 
sodium benzoate. 
 The stx1gene is encoded by a cryptic prophage, CP-933V, in E. coli O157:H7 
strain EDL933 (32). Shiga-toxin production can be stimulated by the SOS response or 
growth under limited iron conditions (23, 32, 42). The effect of macrolide and quinolone 
antibiotics has been reported to increase Shiga-toxin production via phage induction 
associated with a bacterial SOS response or phage-induced cell lysis (23, 43). However, 
information on the response of stx1 to food antimicrobials is lacking. Leenanon et al. 
(25) described an increase in production of stx-2 mRNA for E. coli O157:H7 following 
acid adaptation or starvation. When the gene product of stx-2 was monitored with lacZ 
fusions, there was no increase in -galactosidase activity (25). This could be due to an 
increased sensitivity of RT-PCR assays when compared to -galactosidase activity, or an 
indication that post-transcription control of toxin production may be involved (25). 
Therefore, it is important to understand that our data are only indicative of increased 
transcription of stx1, which may not lead to a subsequent increase in translation of Stx-1 
or release of this toxin from the bacterial cell. Further work by Elhanafi et al. (2004) on 
cold and cold-acid stress of E. coli O157:H7 showed no effect on translation of  Stx2, 
HylA, or EaeA production, but HylA and EaeA production were stimulated in an acidic 
environment (12).  Our data also do not show any increase in eaeA gene expression 
between treated and untreated cells. This could indicate that once intimate attachment 
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onto microvilli occurs, increase in eaeA expression is probably not critical for the 
organism to grow and survive. However, it is likely that the level of expression of the 
Shiga-toxins, and subsequent translation and toxin release, play critical roles in causing 
pathogenic effects in the host, increasing the virulence and survival of the pathogen.   
Conclusions 
These data indicate that stx1 and marA genes could play a role in E. coli O157:H7 
virulence and enhanced survival if cells are exposed to sodium benzoate, while eaeA 
transcription was not altered. It is very important to understand the genetic response of 
pathogens when exposed to antimicrobials in order to assess risk and minimize illness 
from foodborne pathogens. While RT-PCR reactions can give insight to specific gene 
expression responses, microarray technologies give researchers the ability to look at the 
transcription response of all known genes for a microorganism. Our future goals include 
transcriptome analysis of E. coli O57:H7 treated with sodium benzoate using 
microarrays to obtain further insights into gene expression and gene regulation. 
Understanding gene regulation by validating microarray results will aid in mapping out 
metabolic pathways and mechanisms of bacterial survival and adaptations to stress. This 
ultimately will lead to improvements in design and implementation of appropriate 
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Table 2.1.  Primers for rt-RT-PCR assays to determine mRNA expression of stx1, marA, 
and eaeA in E. coli O157:H7 when exposed to 0 and 1% sodium benzoate. 







stx1F GTGGCATTAATACTGAATTGTCATCA 65 83.5 108 
stx1R GCGTAATCCCACGGACTCTTC    
marAF CGAGGACAACCTGGAATCAC 59 86 261 
marAR TGCGGCGGAACATCAAAG    
eaeAF GGCATGAGTCATACAATAAGAAAG 61 84 223 
eaeAR ATCGTCACCAGAGGAATCG    
hemXF GAAAATATTCGCTCTCGCCTGCTGG -1 88 209 
hemXR TGGCTTTGCAGGGTTTCCGG    
1 Primer set for the housekeeping gene, hemX, was utilized in all rt-RT-PCR reactions 
using the optimal annealing temperature for each specific gene target. 
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Table 2.2.  Average cycle threshold (Ct) and limit of detection for marA, stx1, eaeA, and 




0% sodium benzoate 1% sodium benzoate 
Average1 




Ct value ± S.D. 
Limit of 
detection 
marA 34.1 ± 0.6 10-6 36.1 ± 0.75 10-7 
stx1 40.0 ± 0.25 10-5 40.2 ± 0.7 10-6 
eaeA 36.2 ± 0.6 10-6 35.5 ± 0.46 10-6 
hemX 28.4 ± 0.33 10-3 27.3 ± 0.36 10-3 
1 Minimum of  three replicates; S.D. = one standard deviation. 
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Figure 2.1. An example analysis of RT-PCR with marA mRNA showing the limit of 
detection and Ct values for 0 and 1% sodium benzoate-treated E. coli O157:H7.
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Figure 2.2.  Melt temperature analysis of rt-RT-PCR products for A) marA, B) stx1, C) 
eaeA, and D) hemX. 
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Figure 2.3.  Agarose gel electrophoresis validation of A) marA and B) stx1 rt-RT-PCR 
products (from three replicates) to verify a 10-fold increase in transcription of these 





Increased Transcription of the Phosphate Specific Transport 
(Pst) System of Escherichia coli O157:H7 Exposed to 0.5% Sodium 
Benzoate Determined with High-density Oligonucleotide 





Sodium benzoate is a widely used food antimicrobial in drinks and fruit juices. A 
microarray study was conducted to determine the transcriptional response of 
Escherichia coli O157:H7 to 0.5% (w/v) sodium benzoate, and the phosphate specific 
transport (Pst) system was found to be highly up-regulated. The Pst system is composed 
of four subunits: PstS, a periplasmic phosphate binding protein; PstA and PstC, involved 
in formation of the transmembrane portion of the Pst system; and PstB, an ATPase. This 
system transports inorganic phosphate into bacterial cells under phosphate limited 
conditions. Stationary phase E. coli O157:H7 grown in 150 ml Luria-Bertani broth (LB) 
was exposed to 0 (control) and 0.5% sodium benzoate. Each treatment was duplicated, 
sampled at 0 (immediately after exposure), 5, 15, 30, and 60 min. Total RNA was 
extracted and analyzed with E. coli 2.0 Gene Chips. Significant ontology categories 
affected by sodium benzoate exposure were determined with JProGO software.  
Increased expression of the Pst system was observed after 5 min of exposure to 
sodium benzoate; pstS, pstA, pstB, and pstC genes were up-regulated >2-fold (linear 
scale) at 5, 15, 30, and 60 min. Increased expression of several other efflux systems, 
such as AcrAB-TolC, was also observed.       
The Pst system may act as an efflux pump under these stress-adapted conditions, as 
well as increase transport of phosphorus to aid in DNA, RNA, ATP, and phospholipid 
production. Understanding adaptations of E. coli O157:H7 under antimicrobial exposure 
is essential to better understand and implement methods to inhibit or control its 




E. coli O157:H7 is a member of the enterohemorrhagic E. coli (EHEC) and causes 
hemorrhagic colitis in humans.  The symptoms of an E. coli O157:H7 infection generally 
include severe abdominal cramps and diarrhea (often times bloody), which can lead to 
death. In children under the age of five, infection can lead to a complication known as 
hemolytic uremic syndrome (HUS), resulting in red blood cell destruction, renal failure, 
and central nervous system complications (43).  E. coli O157:H7 can cause disease at a 
low infectious dose (10 - 100 cells) (39). This can be attributed to the tolerance of this 
bacterium to low pH, which allows passage through the stomach and colonization in the 
intestinal tract (39).  E. coli O157:H7 has been linked as the causative agent in outbreaks 
associated with unpasteurized apple and orange juice, and experimental data 
demonstrate the tolerance of E. coli O157:H7 to acidic environments (5, 13, 40, 47).     
While it is very hard to quantify the impact foodborne illnesses have in the United 
States, it has been estimated that foodborne disease causes 76 million illnesses annually 
and approximately 5,000 fatalities (36).  There were 16,614 laboratory-confirmed cases 
of foodborne illness from FoodNet participants in 2005 (about 15% of the United States 
population), and E. coli O157:H7 was the causative agent in 2.8% of these cases (3).  The 
Centers for Disease Control and Prevention estimates that there are 73,000 cases of E. 
coli O157:H7 illness annually, leading to an estimated 2,100 hospitalizations in the 
United States (9).  It was estimated that the cost of EHEC infections was $405 million 
dollars in 2003 (22).   
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 The well-described virulence factors of E. coli O157:H7 include stx1, stx2, and 
eaeA (27, 45).  Shiga toxins are composed of two subunits. The B-subunit binds 
glycolipids in the host, and the A-subunit inhibits protein synthesis via disruption of 
ribosomal RNA (1). Shiga-toxins also cause hemorrhagic colitis, hemolytic uremic 
syndrome (HUS), thrombocytopenia, hemolytic anemia, and renal failure (26). The gene 
eaeA in enterohemorrhagic E. coli produces intimin, a 97-kDa protein that plays a role in 
attachment onto and effacement of microvilli of the intestine (16, 21, 31, 35, 51).   
Sodium benzoate is a food additive commonly used in acidic beverages due to its 
relatively low pKa (4.2) and increased solubility (compared to benzoic acid).  This 
compound is generally recognized as safe and may be added at concentrations up to 
0.1% in foods (21CFR184.1733). Benzoate is degraded in microorganisms via the -
ketoadipate pathway resulting in acyl CoA and succinic acid (12).  These degradation 
pathways serve as innate responses to weak acid resistance. 
 A general mechanism of inhibition for weak-acids starts with diffusion of the 
undissociated compound through the cell membrane by passive diffusion.  Once inside 
the cell, the higher pH causes dissociation of the acid and lower intracellular pHi and 
inhibition of membrane-bound transport (8).  Eklund  (17) determined that uptake 
inhibition contributed to growth inhibition, but did not seem to completely explain this 
phenomenon.  Eklund (20) found that ΔpH (pH difference) was eliminated by sorbic acid 
as well as methyl and butyl paraben,  whereas the membrane potential (Δψ) was 
maintained (19).  This indicates more than simple inhibition of the proton motive force, 
since the membrane potential maintained would allow for uptake of essential 
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compounds for cellular maintenance.  It has been determined that dissociated weak 
acids also contribute a small portion to growth inhibition, which cannot be explained by 
the effects of pHi(18).  Sorbic acid, sorbic alcohol and sorbic aldehyde have been found 
to cause similar levels of inhibition, demonstrating a mechanism of inhibition other than 
a weak acid effect (49).  Bracey and others (7) found that pHi was not altered in 
Saccharomyces cerevisiae exposed to sorbic acid.  However, a higher ADP/ATP ratio was 
found indicating that the cell was expending energy to maintain pHi (7), and this 
expenditure of ATP was theorized to decrease cellular growth. 
 Membrane disruption has also been attributed as a mechanism of inactivation by 
sorbic acid (7, 49).   Krebs and et al. (29) observed a reduction in phosphofructokinase 
activity in Saccharomyces cerevisiae exposed to sorbic acid (29).  The disruption of 
glycolysis was thought to be caused by a decrease in pHi that decreased the enzymatic 
activity of phosphofructokinase.  Nitrogen starvation and benzoic acid treatment inhibit 
growth of Saccharomyces cerevisiae.  However, when used in combination, they are 
cytocidal (23).  It was found that benzoic acid inhibited the break-down of cytosolic 
compounds to form amino acids and nucleotides necessary for growth and survival (23).  
Phosphate Specific Transport (Pst) of Escherichia coli 
 The acquisition of phosphorus is essential for bacteria to supply energy and 
synthesize DNA, RNA, lipopolysaccharides, and phospholipids.  Microorganisms must 
transport inorganic phosphorus (Pi) into the cytoplasm to survive.  The first step in this 
process for E. coli is to transport organic and inorganic forms of phosphorus across the 
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cell wall.  In E. coli, there are two common pore-forming proteins, OmpC and OmpF.  
However, under phosphate limited situations, a third anion binding porin, PhoE, is 
expressed in order to sequester phosphorus in the periplasm (41).   
 The Pst system is in the ATP binding cassette (ABC) superfamily of transporters 
and is one mechanism of transporting Pi across the cell membrane.  This system is 
known to be expressed when Pi concentration is below 0.001 M (50).  The Pst system 
has a high affinity for binding of phosphate and is composed of four proteins, PstS, PstC, 
PstA, PstB, and PhoU (50).  The mechanism by which phosphate is transported across 
the cell membrane is shown in Figure 3.1.  All tables and figures are found in an 
appendix located at the end of the chapter.  The gene pstS (formerly phoS) encodes a 
phosphate binding protein that binds Pi in the periplasmic space where it can be 
transported across the cell membrane (37, 38, 52).  PstC and PstA are transmembrane 
proteins that form a passage across the cell membrane (14), while PstB catalyzes the 
movement of phosphorus into the cytoplasm by hydrolysis of ATP (11).   
 PhoR and PhoB regulate the Pho regulon, of which the Pst system is a member.  
PhoR is a transmembrane signal transduction protein that senses low levels of Pi in the 
periplasm.  PhoR has an extracellular sensory domain and an intracellular signaling 
domain (48).  The mechanism by which phosphate concentration is sensed by PhoR is 
shown in figure 3.2.  Under phosphate limited conditions, PhoR undergoes 
autophosphorylation and acts as a histidine kinase that phosphorylates PhoB (Figure 
3.2) (33, 34).  Once PhoB is activated, it stimulates the Pho regulon by binding to the 
‘Pho box’ consensus sequence stimulating transcription of pstS  (32, 33).  In addition to 
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pstSCAB-phoU, PhoB also regulates the expression of PhoA, which is a periplasmic 
alkaline phosphatase that frees Pi from phosphate containing compounds so it is 
available for uptake into the cytoplasm.  PhoU is a 21 kDa cytoplasmic protein that is 
necessary for repression of the Pho regulon (2, 34).  PhoU acts with phosphate-bound 
PstS, PstA, PstB, and PstC to form a repressor complex keeping PhoR in the 
dephosphorlyated state (Figure 3.3).  PhoU also acts to promote dephosphorylation of 
PhoB, thus inactivating this protein (48).   
 A role other than phosphate transport has been determined for the Pst system in 
Mycobacterium smegmatis.  A ciprofloxacin-resistant strain of M. smegmatis strain was 
found to over-express the Pst operon when grown in sufficient quantities of phosphorus 
(4, 6, 10). The pstB gene was also shown to have increased amplification on the 
chromosome of the ciprofloxacin-resistant strain of M. smegmatis  (10).  When the pstB 
gene was mutated, the minimum inhibitory concentration of ciprofloxacin for M. 
smegmatis was greatly reduced (4).  It was also demonstrated that the ciprofloxacin 
resistant strain had a much greater efflux of this fluoroquinolone from the cell 
compared to that of the wild type or pstB mutant (4).  The fluoroquinolone resistant M. 
smegmatis strain showed increased phosphate uptake that was diminished along with 
ciprofloxacin resistance when pstB was mutated (6).  These results indicate that the Pst 
system serves as an efflux mechanism of ciprofloxacin for M. smegmatis in addition to 
the traditional role as a high-affinity transporter of phosphorus.       
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Materials and Methods 
Escherichia coli O157:H7 
Escherichia coli O157:H7 strain EDL 933, obtained from the National Food Safety 
and Toxicology Center at Michigan State University, was used for this study. Cultures 
were grown in 125 ml Luria-Bertani broth (LB; Difco, Becton Dickinson Microbiology 
Systems; Franklin Lakes, NJ) at 37˚C for 24 h, and transferred a minimum of three 
successive times at 24-h intervals before use.  The entire volume of stationary-phase 
cells were centrifuged at 8000 x g for 10 min at 4˚C.  The cell pellet was resuspended in 
LB containing 0 (control) or 0.5% (w/v) sodium benzoate (Fisher Scientific; Fair Lawn, 
NJ).  At every sampling time, cell counts were determined by surface plating on Sorbitol 
MacConkey Agar (SMAC; Difco, Becton Dickinson Microbiology Systems; Franklin Lakes, 
NJ.  
Experimental Design 
 A completely randomized design with repeated measures was used to study the 
effects of sodium benzoate exposure on E. coli O157:H7.  The control (0%) and 
treatment (0.5%) sodium benzoate conditions were replicated once and sampled over 
five time points [0 (immediately after exposure), 5, 15, 30, and 60 min].     
Total RNA Isolation 
The RNeasy Mini Purification Kit (Qiagen; Valencia, CA) was used to extract total 
RNA from E. coli O157:H7 cultures.  1.2 ml RNAlater Stabilization Reagent (Qiagen; 
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Valencia, CA) was combined with 0.6 ml E. coli O157:H7.  RNAlater immediately 
stabilizes RNA to help safeguard against degradation of mRNA.  After 10 min at room 
temperature, the mixture was centrifuged at 8000 x g for 10 min under refrigeration 
(Eppendorf 5417C; New York, NY).  The supernatant was decanted and the bacterial 
pellet was stored at -70˚C until further processed (approx. 2-10 hr). 
 100 µl tris-EDTA buffer (10 mM Tris-Cl, 1 mM EDTA, ph 8.0; Promega; Madison, 
WI) containing lysozyme (3 mg/ml; Sigma-Aldrich; St. Louis, MO) was added to each cell 
pellet.  The pellet was thoroughly mixed and incubated at room temperature for 10 min.  
This allowed for disruption of the cell wall and membrane to allow for extraction of 
RNA.  350 µl buffer RLT was combined with the tris-EDTA/lysozyme cell suspension to 
further lyse the cells.  Buffer RLT contains guanidine thiocyanate which aids in 
denaturing proteins, effectively inactivating ribonucleases to preserve RNA quality.  The 
total volume was combined with 250 µl of 200 proof ethanol (Aaper Alcohol; Shelbyville, 
KY) to solubilize the cell lysate, and the entire sample was transferred to the RNeasy 
Mini spin column in a collection tube and centrifuged at 8000 x g for 15 sec at room 
temperature (Sorvall Biofuge Pico; Kendro, Germany).  The silica-based membrane 
efficiently binds up to 100 µg of RNA longer than 200 bases.  The collection tube and 
eluate were discarded, and the spin column was placed in a new collection tube.  700 µl 
buffer RW1 was applied to the column, centrifuged, and flow-through was discarded as 
described previously.  RW1 also contains guanidine thiocyanate to help disrupt protein 
structure and ethanol to solubilize and remove other cellular material.  Twice, 500 µl of 
buffer RPE was applied to the spin column allowing 5 min prior to centrifugation at 8000 
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x g for 15 sec.  Ethanol also is a constituent of RPE and serves a primary role of removing 
residual salts from previous buffers.  The spin column was placed in a 1.5 ml collection 
tube that was used for long-term storage.  In order to elute RNA from the spin column, 
30 µl RNase-free water was applied directly to the membrane and centrifuged at 8000 x 
g for 15 sec.  Ten RNA samples were extracted for each treatment and replicate (40/ 
time point).  The ten samples were pooled and re-aliquoted to remove variation in RNA 
concentration from differing RNA extraction efficiencies.  The RNA eluate was stored at -
80˚C until evaluated for quantity, quality, and purity.   
Evaluation of RNA Quality, Quantity, and Purity 
 The NanoDrop spectrophotometer (NanoDrop Technologies; Wilimington, DE) 
was utilized to determine absorbance of samples at 230, 260, and 280 nm.  RNA 
concentration is determined by absorbance at 260 nm (1 absorbance unit=40 µg/ml).  
The A260 / A230  and A260 / A280 ratios indicate contamination (e.g. proteins, ethanol, salts) 
and should fall between 1.8 to 2.1.  Lower ratios may interfere with down-stream 
processing of RNA for microarrays and RT-PCR. 
 In addition to spectrophotometric analysis, RNA samples were also analyzed for 
quality using the Agilent 2100 electrophoresis bioanalyzer (Agilent Technologies; Santa 
Clara, CA).  This analysis allows for visualization of 23S and 16S rRNA bands, assuring 
that there is no degradation of RNA and the absence of chromosomal DNA.   
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High Density Oligonucleotide Microarray Analysis 
cDNA Synthesis 
 The Affymetrix protocol for GeneChip prokaryotic processing was followed for 
this study.  In vitro synthesized polyadenylated transcripts for Bacillus subtilis 
(Affymetrix; Santa Clara, CA) were diluted 1 x 10-2.5 and spiked-into the primer annealing 
master mix at a volume of 2 µl.  This “spike-in” is evaluated in the final processing of the 
microarray as a means of monitoring the assay sensitivity and performance from the 
beginning to final stages. Ten micrograms of total RNA was added to the primer 
annealing master mix (final concentration 0.33µg/µl).  Ten microliters of random 
primers (Invitrogen; Carlsbad, CA) at a concentration of 75 ng/µl (final concentration 25 
ng/µl) and nuclease-free water (Ambion; Austin, TX) were added to bring the entire 
master mix volume to 30 µl.  The following conditions were utilized to anneal random 
primers:  70˚C for 10 min; 25˚C for 10 min; chill to 4˚C (PCR Sprint Thermal Cycler; 
Thermo Fisher Scientific; Waltham, MA).   
 The RNA/primer master mix was centrifuged at 5000 x g for 1 min at room 
temperature.  The SuperScript first-strand synthesis system (Invitrogen; Carlsbad, CA) 
reagents and SUPERase-In (Applied Biosystems; Foster City, CA) were combined with the 
30 µl RNA/primer master mix as described in Table 3.1.  The cDNA synthesis conditions 
were:  25˚C for 10 min; 37˚C for 60 min; 42˚C for 60 min; 70˚C for 10 min; chill to 4˚C.  
Remaining RNA was degraded with the addition of 20 µl/rxn of 1N NaOH and incubated 
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at 65˚C for 30 min.  The reaction was neutralized with the addition of 20 µl/rxn of 1N 
HCl. 
Purification and Quantitation of cDNA 
 The MinElute PCR Purification Kit (Qiagen; Valencia, CA) was utilized to clean up 
the cDNA synthesis product prior to further microarray processing.  Five volumes of 
buffer PB were added to the cDNA product, placed on a MinElute spin column, and 
centrifuged at room temperature at 5000 x g for 1 min.  Eluate was discarded and 750 µl 
of buffer PE was applied to the column and centrifuged as described above.  Residual 
ethanol from the PE buffer was allowed to evaporate from the spin column prior to 
eluting cDNA with 12 µl buffer EB.  The resulting purified product was analyzed as 
previously described with the NanoDrop spectrophotometer to determine cDNA yield.   
cDNA Fragmentation 
Purified cDNA (3 µg) was combined with 10X One-Phor-All buffer (GE Healthcare; 
Buckinghamshire, England), DNAse I (0.6 U/µl; GE Healthcare; Buckinghamshire, 
England), and nuclease-free water as described in Table 3.2.  The reaction was held at 
37˚C for 10 min followed by 98˚C for 10 min to inactivate DNAse I. 
Terminal Labeling 
The GeneChip DNA Labeling Reagent (Affymetrix; Santa Clara , CA) was used to 
label the 3’ termini of the fragmented cDNA products with biotin.  Volumes of reagents 
utilized in this reaction are listed in Table 3.3.  The reaction was held at 37˚C for 60 min 
followed by addition of 2 µl of 0.5M EDTA (Invitrogen; Carlsbad, CA) to arrest the 
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labeling reaction by inactivating the terminal deoxynucleotidyl transferase (Promega; 
Madison, WI). 
cDNA Target Hybiridization 
The biotin labeled, fragmented cDNA was added to the hybridization master mix.  
Table 3.4 describes the reagents utilized in this reaction.  The B2 control oligo acts as a 
hybridization control and allows for alignment of the GeneChip microarray in the 
analysis software.  Herring sperm DNA was used as a blocking agent during hybridization 
to prevent improper annealing of cDNA fragments with probes.  
The E. coli Genome 2.0 Array (Affymetrix; Santa Clara, CA) was allowed to 
equilibrate to room temperature. This GeneChip allows detection of transcripts from E. 
coli K12 (MG1655) as well as a uropathogenic strain (CFT073) and two 
enterohemorrhagic strains of the serotype O157:H7 (EDL933 and Sakai).  200 µl of the 
hybridization solution was added to the GeneChip and the array was placed in the 
hybridization oven (Affymetrix; Santa Clara, CA) at 45˚C, 60 RPM for 16 hr.  The 
hybridization solution was then removed and replaced with 80 µl of non-stringent wash 
buffer (wash buffer A; 6x SSPE, 0.01% Tween-20) and the GeneChips were stored at 4˚C 
until washed and stained.   
GeneChip Washing, Staining, and Scanning 
The GeneChip Operating Software (GCOS; Affymetrix; Santa Clara, CA) controlled 
the operation of the Fluidics Station 450 (Affymetrix; Santa Clara, CA).  Streptavidin 
phycoerythrin (SAPE; Table 3.5) was loaded into the first and third 1.5 ml staining vial in 
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the fluidics station, while the second stain vial contained an antibody solution mix (Table 
3.6).  The Mini_prok2v1_450 fluidics station protocol (Table 3.7) was followed for 
washing and staining hybridized biotin labeled cDNA fragments.  The GeneChip Scanner 
3000 (Affymetrix; Santa Clara, CA) and GCOS were used to produce .cel files which 
contained the fluorescence intensity data for a probe.  Each target sequence contains 11 
25-oligomer probes that are spread throughout the entire sequence (perfect match) as 
well as 11 25-oligomer probes that match the target with the exception of the 13th 
nucleotide which is a mismatch to the desired target sequence and indicates non-
specific binding (mismatch).  Fluorescence data for these 22 probes are combined into a 
probe set for further analysis.   
Statistical Analysis of Microarray Data 
 The R programming environment (v 2.5.1) was used for all microarray data 
analysis.  First, GCOS generated CEL files, CDF file, and probe file were uploaded into the 
GCRMA package (v 2.0.0) (54).  This program normalizes microarray data by using 
Affymetrix probe sequence affinities based on the specific probe sequence in addition to 
normalization from background noise also used in robust multiarray average (RMA) 
analysis.  Following normalization with the GCRMA package, the intensities for probe 
sets were compared among treated and control cells across all time points using the 
microarray analysis of variance package (MAANOVA; v 1.4.1) (53). Next, the positive 
false discovery rate (pFDR; q-value) was determined to differentiate genes which were 
significantly regulated in response to exposure of sodium benzoate (qvalue; v 1.10.0) 
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(15).  A subset of genes which were differentially regulated (q < 0.05) were determined 
and used for further analysis. 
Selection of genes for validation with real-time one-step reverse-
transcriptase PCR (rt-RT-PCR) 
    Three tools were used to analyze microarray results so a subset of significantly 
regulated genes could be selected for further validation with rt-RT-PCR.  The Pathway 
Tools Omics Viewer (SRI International; Menlo Park, CA) was used to visualize metabolic, 
transport, and signaling pathways in addition to proteins integral to the membrane and 
periplasm specific to E. coli O157:H7 (42).  The output would link through pathway tools 
to EcO157Cyc (SRI International; Menlo Park, CA) and give further insight to pathways, 
molecular interactions, proteins, and genes.  However, the database specific to E. coli 
O157:H7 was computationally generated with very little curation based on findings in 
current literature.  When the pathways of interest were homologous to E. coli K-12, the 
EcoCyc database which receives extensive literature based curation was utilized to gain 
further insight to functional and regulatory information for a pathway of interest (28).   
 A tool was also used to analyze the gene products that were significantly 
regulated with respect to their biological processes, cellular components, and molecular 
functions.  These ontology terms were analyzed with the Java Tool for the Functional 
Analysis of Prokaryotic Microarray Data using the Gene Ontology (JProGO; 
Braunschweig, Germany) (46).  Wilcoxon’s nonparametric test was used to determine 
statistically significant ontology nodes using an FDR multiple hypothesis correction 
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(p<0.05).  These outputs allowed for selection of genes which would undergo further 
validation of expression using rt-RT-PCR.  
Selection of housekeeping genes for standardization of rt-RT-PCR  
 Secondary validation of microarray data was achieved with the Pfaffl method 
which incorporates the efficiency of a PCR reaction in addition to the difference in Ct 
values between the treated and control samples (44).  The equation below shows how 
the ratio is calculated to determine increased or decreased levels of target mRNA when 
comparing the control and treated sample.  This difference is also standardized with one 
or more reference or housekeeping genes which are expressed at the same level 
between the control and treatment. 
 
From the microarray data, genes were selected which had a highly non-
significant q-value (q>0.98).  Genes were excluded if their function was not known, or if 
there was a high amount of variability between replicate microarrays.  rt-RT-PCR was 
used to validate these genes as appropriate housekeeping markers for microarray 
validation.  Each sample was run in triplicate and there were a total of six cycle 
threshold values for each treatment within each time point.  A completely randomized 
design with repeated measures was used to assure there was no difference in cycle 
threshold values within each time point (p > 0.05; SAS v9.1; Cary, NC).  This 
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methodology helped to assure that there was no difference in mRNA expression 
between treatments.  
Nucleic Acid Amplification 
rt-RT-PCR was performed on RNA extracts as a means of microarray validation. 
SuperScript™ III Platinum® SYBR® green one-step rt-RT-PCR kit reagents (Invitrogen; 
Carlsbad, CA) were utilized in 25 µl reactions (2.5 µl serially-diluted RNA, 12.5 µl SYBR® 
green reaction mix, 1 µl BSA, and 0.5 µl SuperScript™ III reverse transcriptase/Platinum® 
Taq Mix, 0.025 µg forward and reverse primers for the target gene, and the remainder 
RNase-DNAse free water). Primer sequences (Table 3.8) were developed using Beacon 
Designer 4.0 software (Premier Biosoft International; Palo Alto, CA).  The Bio-Rad My 
iQ™ single color real-time PCR detection system (Hercules, CA) was used to conduct rt-
RT-PCR using the following parameters: 1) conversion of mRNA to cDNA, 35 min at 50˚C; 
2) denature reverse-transcriptase, 2 min at 94˚C; 3) denature template, 30 sec at 94˚C; 
annealing of primers, 45 sec at 55˚C; and extension with Taq polymerase, 30 sec at 72˚C; 
repeated 40 times; 4) final extension, 5 min at 72˚C; 5) melt curve .  All rt-RT-PCR 
experiments were conducted in triplicate for each RNA sample and a negative control 
was included for each assay.  
Results and Discussion 
Microarray analysis revealed a large number of genes that were significantly 
regulated in response to 0.5% sodium benzoate.  As shown in Table 3.9, the number of 
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genes which were differentially regulated increased with exposure time, and after 60 
minutes of exposure to sodium benzoate 1707 genes were found to be differentially 
expressed (q≤0.05). 
Ontology analysis allowed for insight to genes which responded to sodium 
benzoate exposure based on biological process, molecular functions, or cellular 
components.  Genes categorized into biological processes were the greatest to respond 
across all time points (Table 3.10).  There were a large number of genes associated with 
biological process nodes which responded quickly to sodium benzoate exposure (0 and 
5 min).  Most of these nodes were associated with metabolic activities such as protein 
biosynthesis.  Genes associated with the ribosome and RNA binding were also found for 
these early time point.  Genes involved in protein translation respond very early to the 
stimulus of sodium benzoate. 
 There was a rapid decline in significant ontology categories at 15 min, but an 
increase was observed for 30 and 60 min.  At 15 min the biological process nodes 
represented genes that responded to unfolded proteins and alcohol metabolism.  
Significant cellular component nodes were found for genes involved with the cell 
membrane.  Genes were also found to be regulated that responded to the molecular 
functions of carbohydrate transport and nickel ion binding.   
Genes associated with molecular functions and cellular components had a 
greater response to sodium benzoate after 30 and 60 min of exposure.  Molecular 
function nodes which had increased expression at these time points pertained to RNA 
and ATP binding activity as well as carbohydrate transport.  The significant cellular 
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component nodes at these times were oriented around the ribosome and products 
which were integral to the membrane or part of the inner membrane.  Biological 
process nodes associated with a response to chemical and antibiotic stimuli were found 
after 15 min of exposure and continued until 60 min.  Many of these genes are 
components of efflux pumps as well as transcription regulators, such as marA, the 
multiple antibiotic resistance regulon activator.   
Phosphate transport was one biological process node which was significantly 
regulated at 30 and 60 min.  This insight spurred a closer look at this finding.  Increased 
expression after only 5 min was found for all genes associated with the high affinity 
phosphate transport system (pstSCAB-phoU) when E.coli was exposed to sodium 
benzoate.  Therefore, validation of the genes integral to the pst system as well as the 
transcriptional regulators (phoRB) for this operon was conducted using the Pfaffl 
method.  
The glutamine synthetase adenyltransferase (glnE) gene catalyzes the addition of 
AMP to a subunit of glutamine synthetase.  PspF is a σ54 dependent transcriptional 
activator that is cis-acting on the phage-shock protein (psp) operon and has been found 
to be constitutively expressed (24, 25).  No significant differences were found in Ct 
values for these genes across treatments within time points (p > 0.05).  Therefore, glnE 
and pspF were utilized as the housekeeping genes by which rt-RT-PCR assays were 
normalized in the Pfaffl method.     
The log2 fold-change between 0.5% sodium benzoate treated E. coli O157:H7 
cells and that of the control conditions is shown in Table 3.11.  Microarray generated 
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values for the pstSCAB and phoBR genes in the Pho regulon indicate at least a 2.8-fold 
induction (linear-scale) when E. coli O157:H7 was exposed to sodium benzoate.  When 
these values were validated with rt-RT-PCR, phoB and phoR transcription levels were not 
as high as indicated by microarray analysis.  The microarray results indicated an 11- to 
17-fold increase in transcription of phoB, and at least a 34-fold induction of phoR when 
assessed on a linear scale.  However, when determining transcript levels with rt-RT-PCR, 
the highest induction observed was a 5.2-fold increase for phoB at 5 min.  This indicates 
that for these two transcripts, there was increased probe fluorescence seen in the 
microarray analysis.  This could be attributed to non-specific binding of cDNA to probe 
sets in the microarray assay, which would arbitrarily increase the observed fluorescence.  
Also, typically the Affymetrix prokaryotic microarrays are only exposed once with 
phycoerythrin, but in this study all arrays were exposed twice to this fluorophore.  This 
could also increase the level of fluorescence, but since all arrays were processed in the 
same manner this result should have been negated when determining the ratio of the 
control to treated conditions.  Also, when comparing the induction levels for pstSCAB 
observed in microarray and rt-RT-PCR, very similar results were obtained (Table 3.11).  
This support non-specific binding to the phoBR probes in the Affymetrix E. coli 2.0 
microarrays, thereby artificially inflating the fluorescence values obtained.  This stresses 
the importance of validating microarray results with a secondary method such as rt-RT-
PCR or Northern hybridization.  Nevertheless, increased transcription was observed for 
pstSCAB and phoBR when E. coli O157:H7 was exposed to 0.5% sodium benzoate (Table 
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3.11).  The Ct values and standard deviations obtained from the validation of 
transcription levels with rt-RT-PCR are listed in Table 3.12.  
PhoU was shown to have increased transcription across all time points (Table 3. 
13).  However, these values were not validated with rt-RT-PCR, and like phoBR, may 
have arbitrarily high fold-changes detected with microarrays.  The polyanion porin, 
PhoE, was not found to be differentially regulated at any time point in the microarray 
study.  This suggests that transcription of this gene is not stimulated under these growth 
conditions.  If phosphate was limited, transcription of this gene should have increased to 
help sequester phosphate and other organic molecules that bound phosphorus from the 
growth medium. 
The pstSCAB-phoU and phoBR genes may have increased transcription to serve 
as an efflux pump in addition to phosphate transport.  Although this phenomenon has 
not been documented in E. coli, it has recently been determined for Mycobacterium 
smegmatis (4, 6).  Several components of other multidrug efflux pumps were also 
shown to have increased transcription in response to exposure with 0.5% sodium 
benzoate (Table 3.14).  Although there are several different systems for transporting 
these compounds from the cytoplasm, only one porin (TolC) is used to span the outer 
membrane.  In this study, tolC transcription was not observed to be increased while the 
proteins that span the cell membrane and periplasm, such as those cited in Table 3.12, 
were shown to have increased expression. 
These results indicate that there is an increased need for phosphate when E. coli 
O157:H7 is exposed to sodium benzoate.  Therefore, if phosphate could be limited, E. 
80 
 
coli O157:H7 could have decreased ability to adapt and survive this stressful 
environment.  If phosphate is depleted, the microorganism’s ability to repair DNA and 
synthesize mRNA would be hampered.  Protein biosynthesis would also be negatively 
influenced that would in turn reduce enzymatic activity.  The cell would also have 
lowered ability to produce lipopolysaccharides and phospholipids in the cell membrane.  
Most importantly, the energy supply of the cell would be greatly impacted under 
restriction of intracellular phosphate.         
The pst system has been found to be a virulence factor in E. coli O78, causes 
airsacculitis and septicemia in poultry.  When the pst system was mutated, the 
infectivity of this strain was attenuated in an avian model and fewer isolates were 
obtained from infected tissues (30).  The mutated strain was also less able to survive 
acid-shock treatment (pH 3.0) when compared to the wild-type and had a two-fold 
lower MIC for polymixin (30).  Although these results were found in an extraintestinal E. 
coli, they indicate that the pst system plays a large role in the ability of E. coli O78 to 
survive and cause illness.  This observation has also been made in Proteus mirabilis, 
which causes complicated urinary tract infections.  When the pstS and pstA genes were 
inactivated with Tn5 insertions, the Pho regulon was constitutively expressed.  Although 
the mutant cells grew and survived in urine and growth media in vitro, they did not 
cause urinary tract infections in a murine model.  When these mutants were 
complemented with functional pstS and pstA, the ability to cause urinary tract infections 
was restored to that of the wild-type.  Both of these examples demonstrate the 




 The pst system is up-regulated in response to sodium benzoate in E. coli 
O157:H7.  This system would give E. coli O157:H7 the ability to recharge intracellular 
phosphate supplies to rapidly produce several compounds such as ATP, nucleic acids, 
and phospholipids in response to this adverse environment.  This system has been 
shown to play a role in virulence and pathogenicity in other microorganisms and is part 
of the adaption of E. coli O157:H7 to weak acids.  In addition to the known role as a 
high-affinity transport system for phosphate, the pst system may also serve as an efflux 
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Table 3.1.  cDNA synthesis master mix components. 
Reagent Volume per reaction (µl) 
5X First-strand cDNA Buffer 12 
100 mM DDT 6 
10 mM dNTP Mix 3 
SUPERase-In (20 U/µl) 1.5 
Superscript II (200 U/µl) 7.5 




Table 3.2.  cDNA fragmentation master mix components. 
Reagent Volume per reaction (µl) 
10x One-Phor-All Buffer 2 
cDNA 15 
DNAse I 1.8 




Table 3.3.  Terminal labeling of cDNA fragments with biotin master mix components. 
Reagent Volume per reaction (µl) 
5x Reaction Buffer 10 
GeneChip DNA Labeling Reagent, 7.5mM 2 
Terminal Deoxynucleotidyl Transferase 2 
Nuclease Free Water 16 



















1 200 mMMES, 2M [Na+], 20 mM EDTA, 0.01% Tween-20 
Reagent Volume per reaction (µl) 
2x Hybirdization Buffer1 40 
3 nM B2 Control Oligo 1.3 
10 mg/ml Herring Sperm DNA 0.8 
50 mg/ml BSA 0.8 
100% DMSO 6.2 
Nuclease Free Water 5.9 










2x MES stain buffer 600 1x 
50 mg/ml BSA 48 2 mg/ml 
1 mg/ml streptavidin 
phycoerythrin 
12 10 µg/ml 










2x MES Stain Buffer 300 1x 
50 mg/ml BSA 24 2 mg/ml 
10 mg/ml Goat IgG 6 0.1 mg/ml 
0.5 mg/ml Anti-streptavidin Antibody 
(goat), Biotinylated 
 
6 5 µg/ml 




Table 3.7.  Mini_prok2v1_450 fluidics station program. 
 
Step Temperature (˚C) Description 
Post Hyb Wash 
#1 
30 10 cycles of 2 mixes/cycle with Wash 
Buffer A 
Post Hyb Wash 
#2 
50 4 cycles of 15 mixes/cycle with Wash 
Buffer B 
1st Stain 35 Stain the probe array for 5 min in SAPE 
2nd Stain 35 Stain the probe array for 5 min in 
Antibody Solution Mix 
3rd Stain 35 Stain the probe array for 5 min in SAPE 
Final Wash 35 5 cycles of 4 mixes/cycle with Wash 
Buffer A  
96 
 
Table 3.8.  Primers for rt-RT-PCR assays to determine mRNA expression of pstS, pstC, 
pstA, pstB, phoB, phoR, glnE, and pspF in E. coli O157:H7 when exposed to 0 and 0.5% 
sodium benzoate. 








TGACACTTACCAGAAAGAAACC 86 233 
pstSR TACCATCCAGCACCAGTTC   
pstCF GCCTTTGGTATCGGTATCC 85 179 
pstCR TTGGTGAACGGAAGAACG   
pstAF GGATTTATCTGGCGGAATATGG 86.5 229 
pstAR TACGGCACCAGTTTCAGC   
pstBF CTTCTACTACGGCAAATTCC 87 379 
pstBR GGTTTCGTTCCACAATGC   
phoBF CGAAGCGGAAGATTATGACAG 83.5 158 
phoBR TCAACATCACCACTGGAATATC   
phoRF TCTGGTGTAACGGTCTGG 85.5 200 
phoRR CAACTGTTTGTGGGTATAAGG   
glnEF GGATGGCTTCGTCTATCG 88 361 
glnER GAGCTGGAACACCTGAAC   
pspFF TCTGCTGGATTCCGAACTG 86.5 226 




Table 3.9.  Number of differentially regulated genes over time (q<0.05) when E. coli 
O157:H7 is exposed to 0.5% sodium benzoate 
Time  
(min) 










Table 3.10.  Number of significant ontology nodes within biological process, cellular 









0 51 8 11 5.1077E-4 
5 57 0 3 5.1851E-4 
15 4 2 6 1.0249E-4 
30 14 10 13 2.7975E-4 




Table 3.11.  Increased transcription of pstS, pstC, pstA, pstB, phoB, and phoR mRNA  in E. 
coli O157:H7 when exposed to 0.5% sodium benzoate and analyzed with high density 
oligonucleotide microarrays and validated with rt-RT-PCR. 
Target 
mRNA Time 




rt-RT-PCR log2  
fold-change 
pstS 0 -0.02 0.141 Nd2 
 5 2.4 9.65 E-6 2.8 
 15 2.7 4.41 E-6 2.7 
 30 2.6 5.14 E-6 2.5 
 60 2.5 6.83 E-6 3.3 
pstC 0 -0.7 0.01 nd 
 5 2.8 6.9 E-6 1.8 
 15 2.9 9.49 E-6 1.7 
 30 2.8 7.42 E-6 1.8 
 60 3.4 5.17 E-6 1.9 
pstA 0 -1.14 0.02 nd 
 5 2.3 2.29 E-5 2.9 
 15 2.5 1.47 E-5 3.1 
 30 2.5 1.62 E-5 3.3 
 60 2.4 1.86 E-5 3.1 
pstB 0 -1.3 0.04 nd 
 5 1.5 0.0003 2.1 
 15 2.0 7.33 E-5 2.0 
 30 1.9 9.25 E-5 2.2 
100 
 
Table 3.11. Continued 
Target 
mRNA Time 




rt-RT-PCR log2  
fold-change 
pstB 60 2.0 7.01 E-5 2.5 
phoB 0 1.9 0.01 nd 
 5 3.8 2.29 E-5 2.4 
 15 3.5 1.8 E-5 2.1 
 30 4.1 1.4 E-5 1.7 
 60 3.8 2.19 E-5 2.2 
phoR 0 2.3 0.001 nd 
 5 5.1 1.53 E-5 2.0 
 15 5.7 8.46 E-6 2.0 
 30 6.0 5.11 E-6 1.6 
 60 5.3 1.32 E-5 1.9 




Table 3.12.  Average cycle threshold (Ct) values (n=6) of rt-RT-PCR for pstS, pstC, pstA, 
pstB, phoB, and phoR mRNA in E. coli O157:H7 when exposed to 0 and 0.5% sodium 
benzoate. 
  0% Sodium Benzoate 0.5% Sodium Benzoate 
Target 





pstS 5 13.93 0.42 10.78 0.91 
 15 13.88 0.22 10.47 0.38 
 30 15.28 0.47 10.72 0.48 
 60 14.41 0.38 10.91 0.17 
pstC 5 15.99 0.3 14.01 0.15 
 15 15.49 0.3 13.25 0.14 
 30 15.25 0.48 12.97 0.43 
 60 15.19 0.3 13.2 0.38 
pstA 5 12.96 0.24 10.40 0.31 
 15 13.15 0.33 10.25 0.18 
 30 13.33 0.46 10.23 0.18 
 60 13.5 0.32 10.91 0.36 
pstB 5 13.27 0.25 10.76 0.53 
 15 13.08 0.41 10.33 0.14 
 30 12.84 0.5 9.84 0.17 
 60 13.29 0.29 10.46 0.4 
phoB 5 14.42 0.65 11.72 0.49 
 15 14.5 0.32 11.8 0.28 
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Table 3.12. Continued 
  0% Sodium Benzoate 0.5% Sodium Benzoate 
Target 





phoB 30 14.85 0.54 11.19 0.17 
 60 14.54 0.27 12.02 0.27 
phoR 5 14.27 0.49 11.65 1.79 
 15 14.24 0.27 11.24 0.1 
 30 15.18 0.58 11.14 0.23 




Table 3.13.  Transcription of phoU mRNA in E. coli O157:H7 when exposed to 0.5% 









phoU 0 -1.7 0.019 
 5 1.3 0.0043 
 15 2.1 0.00041 
 30 1.7 0.0013 




Table 3.14.  Log2 fold changes obtained with microarray studies to determine 
transcription of genes involved in multidrug efflux in E. coli O157:H7 when exposed to 
0.5% sodium benzoate. 
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1Log2 fold change (q-value).  




Figure 3.1.  Diagram of the phosphate specific transport (Pst) system of E. coli O157:H7.  
This system actively transports phosphate across the cytoplasmic membrane under Pi 
starvation conditions (Pi= inorganic phosphate; S=PstS protein that binds phosphate in 
the periplasmic space; A and C are PstA and PstC transmembrane proteins; B= PstB 




Figure 3.2.  Under phosphate limited conditions, PhoU is removed from the repressor 
complex and PhoR undergoes autophosphorylation. Once this occurs, PhoR acts as a 
histidine kinase and phosphorylate PhoB activates the Pho regulon by binding Pho boxes 




Figure 3.3.  Negative regulation of Pho operon by repressor complex comprised of Pi 
bound PstS, PstABC, PhoU, and PhoR.  By this mechanism PhoR is maintained in the 
dephosphorylated repressor form, negatively regulating the Pho operon (Pi= inorganic 
phosphate; S=PstS protein that binds phosphate in the periplasmic space; A and C are 
PstA and PstC transmembrane proteins; B= PstB protein that is the ATP binding domain; 
U=PhoU negative regulator; R=PhoR transmembrane sensor protein; B=PhoB phosphate 





Increased Transcription of the Urease Operon of Escherichia 
coli O157:H7 Exposed to 0.5% Sodium Benzoate Determined 
with High-density Oligonucleotide Microarrays and Reverse-




Sodium benzoate is a widely used food antimicrobial in drinks and fruit juices. 
Understanding gene regulation in E. coli O157:H7 under antimicrobial stress is critical to 
enable the design of appropriate control strategies. High-throughput novel technologies 
such as microarrays enable the study and characterization of gene expression.  
Microarrays were used to determine the transcriptional response of E. coli O157:H7 
after exposure to 0.5% sodium benzoate. 
Stationary phase E. coli O157:H7 grown in 150 ml Luria-Bertani broth (LB) was 
exposed to 0 (control) and 0.5% sodium benzoate. Each treatment was duplicated, 
sampled at 0 (immediately after exposure), 5, 15, 30, and 60 min. Total RNA was 
extracted and analyzed with E. coli 2.0 Gene Chips.Differentially regulated genes 
(positive-false discovery rate < 0.05) were determined using the R-MAANOVA 
(microarray analysis of variance) package.  
Microarray analysis revealed that all genes in the urease operon were up-
regulated > 2-fold (linear-scale) after 60 min exposure to sodium benzoate. The urease 
operon is composed of three structural genes, ureA, ureB, and ureC, and four accessory 
genes, ureD, ureE, ureF, and ureG.  
Urease catalyzes the hydrolysis of urea to ammonia and carbon dioxide, and is 
one mechanism by which microorganisms survive in acidic environments. Ammonium 
ions accumulate in the surrounding environment, effectively mediating a rise in pH. In 
this study, exposure of E. coli O157:H7 to sodium benzoate in a neutral pH environment 
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resulted in an increase in transcription of the entire urease operon. Understanding 
adaptations of E. coli O157:H7 after exposure to antimicrobials is essential to better 




E. coli O157:H7 is a member of the enterohemorrhagic E. coli (EHEC) and causes 
hemorrhagic colitis in humans. The symptoms of an E. coli O157:H7 infection generally 
include severe abdominal cramps and diarrhea (often times bloody), which can lead to 
death. In children under the age of five, infection can lead to a complication known as 
hemolytic uremic syndrome (HUS), resulting in red blood cell destruction, renal failure, 
and central nervous system complications (37).  E. coli O157:H7 can cause disease at a 
low infectious dose (10 - 100 cells) (29). This can be attributed to the tolerance of this 
bacterium to low pH, which allows passage through the stomach and colonization in the 
intestinal tract (29).  E. coli O157:H7 has been linked as the causative agent in outbreaks 
associated with unpasteurized apple and orange juice, and experimental data 
demonstrate the tolerance of E. coli O157:H7 to acidic environments (3, 7, 30, 42).     
While it is very hard to quantify the impact foodborne illnesses have in the United 
States, it has been estimated that foodborne disease causes 76 million illnesses annually 
and approximately 5,000 fatalities (28).  There were 16,614 laboratory-confirmed cases 
of foodborne illness from FoodNet participants in 2005 (~15% of the United States 
population), and E. coli O157:H7 was the causative agent in 2.8% of these cases (2). The 
CDC estimates that there are 73,000 cases of E. coli O157:H7 annually, leading to an 
estimated 2,100 hospitalizations in the United States (6).  It has been estimated that the 
cost of EHEC infections was $405 million dollars in 2003 (16).   
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 The well-described virulence factors of E. coli O157:H7 include stx1, stx2, and 
eaeA (23, 40).  Shiga toxins are composed of two subunits. The B-subunit binds 
glycolipids in the host, and the A-subunit inhibits protein synthesis via disruption of 
ribosomal RNA (1). Shiga-toxins may cause hemorrhagic colitis, hemolytic uremic 
syndrome (HUS), thrombocytopenia, hemolytic anemia, and renal failure (22). The gene 
eaeA in enterohemorrhagic E. coli produces intimin, a 97-kDa protein that plays a role in 
attachment onto and effacement of microvilli of the small intestine (10, 15, 26, 27, 46).   
Sodium benzoate is a food additive commonly used in acidic beverages due to its 
relatively low pKa (4.2) and increased solubility (compared to benzoic acid).  This 
compound is generally recognized as safe and may be added at concentrations up to 
0.1% in foods (21 CFR 184.1733). 
A general mechanism of inhibition for weak-acids starts with diffusion of the 
undissociated compound through the cell membrane by passive diffusion.  Once inside 
the cell, the higher pH causes dissociation of the acid and lower intracellular pHi and 
inhibition of membrane-bound transport (5).  Eklund  (11) determined that uptake 
inhibition contributed to growth inhibition, but did not seem to completely explain this 
phenomenon.  Eklund (14) found that ΔpH (pH difference) was eliminated by sorbic acid 
as well as methyl and butyl paraben,  whereas the membrane potential (Δψ) was 
maintained (13).  This indicates more than simple inhibition of the proton motive force, 
since the membrane potential maintained would allow for uptake of essential 
compounds for cellular maintenance.  It has been determined that dissociated weak 
acids also contribute a small portion to growth inhibition, which cannot be explained by 
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the effects of pHi(12).  Sorbic acid, sorbic alcohol and sorbic aldehyde have been found 
to cause similar levels of inhibition, demonstrating a mechanism of inhibition other than 
a weak acid effect (45).  Bracey and others (4) found that pHi was not altered in 
Saccharomyces cerevisiae exposed to sorbic acid.  However, a higher ADP/ATP ratio was 
found indicating that the cell was expending energy to maintain pHi (4), and this 
expenditure of ATP was theorized to decrease cellular growth. 
 Membrane disruption has also been attributed as a mechanism of inactivation by 
sorbic acid (4, 45).   Krebs and et al. (25) observed a reduction in phosphofructokinase 
activity in Saccharomyces cerevisiae exposed to sorbic acid (25).  The disruption of 
glycolysis was thought to be caused by a decrease in pHi that decreased the enzymatic 
activity of phosphofructokinase.  Nitrogen starvation and benzoic acid treatment inhibit 
growth of Saccharomyces cerevisiae.  However, when used in combination, they are 
cytocidal (18).  It was found that benzoic acid inhibited the break-down of cytosolic 
compounds to form amino acids and nucleotides necessary for growth and survival (18).    
Escherichia coli O157:H7 Urease Operon 
 Escherichia coli O157:H7 is known to produce urea when degrading arginine to 
putrescine (32, 33).  Urease (EC 3.5.1.5) catalyzes the reaction of urea into two 
molecules of ammonia and carbon dioxide (31).  The liberated ammonia results in 
increased pH of the surrounding environment.   Escherichia coli O157:H7 EDL933 
genomic sequence contains an O-island with two urease gene clusters (ureDABCEFG) 
(38).  Urease is composed of three structural proteins, UreA, UreB, and UreC, as well as 
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four accessory proteins, UreD, UreE, UreF, and UreG (31).  This enzyme could give 
enterohemorrhagic E. coli (EHEC) the ability to neutralize acidic environments and allow 
for survival in acidic food products as well as support survival in the gastrointestinal 
tract.   
When studying the presence of the urease gene clusters in E. coli O157:H7 
isolates, it was found that among serotype O157:H7 isolates (n= 59), 98% contained all 
genes in the urease operon(17).  In contrast, none of the genes in the urease operon 
were present in sorbitol-fermenting O157:NM (non-motile) isolates (n=82) (17).   
However, among O157:H7 isolates found to have the urease operon, only one was 
found to have urease activity when evaluated with Christensen’s agar or with the API 
20E system; in this isolate, elevated levels of ammonia could be were detected (17).  
When evaluating nine isolates of serotype O55:H7, from which E. coli O157:H7 has been 
theorized to have diverged, none contained genes in the urease operon (17).   
Similarly, Orth et al.(35) studied the distribution of ureC among 202 EHEC that 
encompassed 61 serotypes.  It was found that all O157:H7 and O157:NM (n=72) that 
displayed the typical non-sorbitol fermenting phenotype possessed the ureC  gene (35).  
However, all sorbitol fermenting  O157:NM isolates (n=8) were negative for ureC (35).  
All isolates containing ureC were also found to contain all genes in the urease 
operon(35).   When the ureC isolates were evaluated for urease production in urease 
degradation broth, only 3.4% showed urease activity (35).  The nucleotide sequence of 
all urease genes present in ten O157:H7 isolates studied were found to have ≥ 99% 
homology (35).  These data indicate that the urease operon was acquired by O157:H7 
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relatively recently and possibly through horizontal gene transfer or gene loss since both 
O55:H7 and sorbitol fermenting O157:NM strains lack the urease gene cluster, and 
although many E. coli O157:H7 isolates contain the urease operon, it is not commonly 
expressed under normal culture conditions. 
Nakano et al.(34) examined urease production by E. coli O157:H7 Sakai in various 
culture media, pH, temperatures, and nutrients via ammonia production without any 
success at stimulating urease production.  When further examining 120 EHEC isolates 
for urease activity, two isolates were identified as being urease positive (34).  All isolates 
were determined to have a urease operon of similar size (4940 bp), and the nucleotide 
sequence was similar for a urease positive strain compared to the Sakai strain except for 
a slightly longer open reading frame in the ureD gene of the urease positive isolate (34).  
It was revealed that the Sakai strain as well as all urease negative EHEC isolates 
examined (n=158) had a premature stop codon for ureD compared to that of the urease 
negative isolate.  When the ureD gene of a urease positive EHEC was transformed into 
the Sakai strain urease production was detected(34).  These data indicate that the 
premature stop codon in UreD plays a role in urease production in vitro.   
When attempting to stimulate urease production in E. coli O157:H7 strain 
EDL933, urease could not be detected using Christensen’s agar, enzymatic assays, or 
immunoblotting techniques  targeting  UreC and UreD (19).  However, when non-
pathogenic E. coli DH5  was transformed with the EHEC ure gene cluster, urease was 
detected via enzymatic activity (19).   This demonstrated that the urease genes present 
in the EDL933 strain were functional, but failed to be expressed under multiple culture 
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conditions.  It is interesting that the ureD nucleotide sequence in strain EDL933 is 
identical to Sakai (34).  When Nakano et al.(34) transformed the Sakai ureD gene into E. 
coli DH5 . urease was detected.  The authors believe that the amber suppressor 
phenotype of DH5  played a role in read-through of the premature stop codon. Heimer 
et al.(19) determined that a trans-acting factor was inhibiting urease transcription in 
EHEC.  These authors also identified three Fur-like (ferric-uptake regulator) recognition 
sites upstream of ureA and ureD (19).  In this study, urease production was detected in 
two other EHEC strains (IN1 and MO28), and a Δfur background greatly diminished the 
urease activity of these strains (19).  This research indicated that Fur, as well as other 
unidentified trans-acting factors, plays a role in regulating the expression of urease in 
EHEC.   
Materials and Methods 
Escherichia coli O157:H7 
Escherichia coli O157:H7 strain EDL 933, obtained from the National Food Safety 
and Toxicology Center at Michigan State University, was used for this study. Cultures 
were grown in 125 ml Luria-Bertani broth (LB; Difco, Becton Dickinson Microbiology 
Systems; Franklin Lakes, NJ) at 37˚C for 24 h, and transferred a minimum of three 
successive times at 24-h intervals before use.  The entire volume of stationary-phase 
cells were centrifuged at 8000 x g for 10 min at 4˚C.  The cell pellet was resuspended in 
LB containing 0 (control) or 0.5% (w/v) sodium benzoate (Fisher Scientific; Fair Lawn, 
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NJ).  At every sampling time, cell counts were determined by surface plating on sorbitol 
MacConkey Agar (SMAC; Difco, Becton Dickinson Microbiology Systems; Franklin Lakes, 
NJ).  
Experimental Design 
 A completely randomized design with repeated measures was utilized to study 
the effects of exposuring E. coli O157:H7 to sodium benzoate.  The control (0%) and 
treatment (0.5%) sodium benzoate conditions were replicated once and sampled over 
five time points [0 (immediately after exposure), 5, 15, 30, and 60 min].     
Total RNA Isolation 
The RNeasy Mini Purification Kit (Qiagen; Valencia, CA) was utilized to extract 
total RNA from E. coli O157:H7.  1.2 ml RNAlater Stabilization Reagent (Qiagen; Valencia, 
CA) was combined with 0.6 ml E. coli O157:H7.  RNAlater immediately stabilizes RNA to 
help safeguard against degradation of mRNA.  After 10 min at room temperature, the 
mixture was centrifuged at 8000 x g for 10 min under refrigeration (Eppendorf 5417C; 
New York, NY).  The supernatant was decanted and the bacterial pellet was stored at -
70˚C until further processed (approx. 2-10 hr). 
 100 µl tris-EDTA buffer (10 mM Tris-Cl, 1 mM EDTA, ph 8.0; Promega; Madison, 
WI) containing lysozyme (3 mg/ml; Sigma-Aldrich; St. Louis, MO) was added to each cell 
pellet. The pellet was thoroughly mixed and incubated at room temperature for 10 min.  
This disrupts the cell wall and membrane and allows for extraction of RNA.  350 µl of 
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buffer RLT was combined with the tris-EDTA suspension to further lyse bacterial cells.  
Buffer RLT contains guanidine thiocyanate which aids in denaturing proteins and 
effectively inactivates ribonucleases to preserve RNA quality.  The total volume was 
combined with 250 µl of 200 proof ethanol (Aaper Alcohol; Shelbyville, KY) to solubilize 
the cell lysate, and the entire sample was transferred to the RNeasy Mini spin column in 
a collection tube and centrifuged at 8000 x g for 15 sec at room temperature (Sorvall 
Biofuge Pico; Kendro, Germany).  The silica-based membrane efficiently binds up to 100 
µg of RNA longer than 200 bases.  The collection tube and eluate were discarded and 
the spin column was placed in a new collection tube. 700 µl of buffer RW1 was applied 
to the column, centrifuged, and flow-through was discarded as described previously.  
RW1 also contains guanidine thiocyanate to help disrupt protein structure and ethanol 
to solubilize and remove other cellular material.  Twice, 500 µl of buffer RPE was applied 
to the spin column allowing 5 min prior to centrifugation at 8000 x g for 15 sec.  Ethanol 
also is a constituent of RPE and serves a primary role of removing residual salts from 
previous buffers.  The spin column was placed in a 1.5 ml collection tube that was used 
for long-term storage.  In order to elute RNA from the spin column, 30 µl of RNase-free 
water was applied directly to the membrane and centrifuged at 8000 x g for 15 sec.  Ten 
RNA samples were extracted for each treatment and replicate (40/time point).  The ten 
samples were pooled and divided into aliquots to remove variation in RNA 
concentration from differing RNA extraction efficiencies. The RNA eluate was stored at -
80˚C until evaluated for quantity, quality, and purity.   
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Evaluation of RNA Quality, Quantity, and Purity 
 The NanoDrop spectrophotometer (NanoDrop Technologies; Wilimington, DE) 
was utilized to determine absorbance of samples at 230, 260, and 280 nm.  RNA 
concentration is determined by absorbance at 260 nm (1 absorbance unit=40 µg/ml). 
The A260 / A280  and A260 / A230 ratios indicate contamination (e.g. proteins, ethanol, salts) 
and should fall between 1.8 to 2.1.  Lower ratios may interfere with down-stream 
processing of RNA for microarrays and RT-PCR. 
 In addition to spectrophotometric analysis, RNA samples were also analyzed for 
quality using the Agilent 2100 electrophoresis bioanalyzer (Agilent Technologies; Santa 
Clara, CA).  This analysis allows for visualization of 23S and 16S rRNA bands, assuring 
that there is no degradation of RNA and the absence of chromosomal DNA.   
High Density Oligonucleotide Microarray Analysis 
cDNA Synthesis 
 The Affymetrix protocol for GeneChip prokaryotic processing was followed for 
this study.  In vitro synthesized polyadenylated transcripts for Bacillus subtilis 
(Affymetrix; Santa Clara, CA) were diluted 1 x 10-2.5 and spiked-into the primer annealing 
master mix at a volume of 2µl.  This “spike-in” is evaluated in the final processing of the 
microarray as a means of monitoring the assay sensitivity and performance from the 
beginning to final stages.  Ten micrograms of total RNA was added to the primer 
annealing mastermix (final concentration 0.33µg/µl).  Ten microliters of random primers 
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(Invitrogen; Carlsbad, CA) at a concentration of 75 ng/µl (final concentration 25ng/µl) 
and nuclease-free water (Ambion; Austin, TX) were added to bring the entire master mix 
volume to 30 µl.  The following conditions were utilized to anneal random primers:  70˚C 
for 10 min; 25˚C for 10 min; chill to 4˚C (PCR Sprint Thermal Cycler; Thermo Fisher 
Scientific; Waltham, MA)   
 The RNA/primer master mix was centrifuged at 5000 x g for 1 min at room 
temperature.  The SuperScript first-strand synthesis system (Invitrogen; Carlsbad, CA) 
reagents and SUPERase-In (Applied Biosystems; Foster City, CA) were combined with the 
30µl RNA/primer master mix as described in Table 4.1.  All tables and figures are found 
in an appendix located at the end of the chapter.  The cDNA synthesis conditions were:  
25˚C for 10 min; 37˚C for 60 min; 42˚C for 60 min; 70˚C for 10 min; chill to 4˚C.  
Remaining RNA was degraded with the addition of 20µl/rxn of 1N NaOH and incubated 
at 65˚C for 30 min.  The reaction was neutralized with the addition of 20µl/rxn of 1N 
HCl. 
Purification and Quantitation of cDNA 
 The MinElute PCR Purification Kit (Qiagen; Valencia, CA) was utilized to clean up 
the cDNA synthesis product prior to further microarray processing.  Five volumes of 
buffer PB were added to the cDNA product, placed on a MinElute spin column, and 
centrifuged at room temperature at 5000 x g for 1 min.  Eluate was discarded and 750 µl 
of buffer PE was applied to the column and centrifuged as described above.  Residual 
ethanol from the buffer PE was allowed to evaporate from the spin column prior to 
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eluting cDNA with 12 µl buffer EB.  The resulting purified product was analyzed as 
previously described with the NanoDrop spectrophotometer to determine cDNA yield.   
cDNA Fragmentation 
Purified cDNA (3µg) was combined with 10X One-Phor-All buffer (GE Healthcare; 
Buckinghamshire, England), DNAse I (0.6 U/µl; GE Healthcare; Buckinghamshire, 
England), and nuclease-free water as described in Table 4.2.  The reaction was held at 
37˚C for 10 min followed by 98˚C for 10 min to inactivate DNAse I. 
Terminal Labeling 
The GeneChip DNA Labeling Reagent (Affymetrix; Santa Clara , CA) was used to 
label the 3’ termini of the fragmented cDNA products with biotin.  Volumes of reagents 
utilized in this reaction are listed in Table 4.3.  The reaction was held at 37˚C for 60 min 
followed by addition of 2µl of 0.5M EDTA (Invitrogen; Carlsbad, CA) to arrest the 
labeling reaction by inactivating the terminal deoxynucleotidyl transferase (Promega; 
Madison, WI) . 
cDNA Target Hybiridization 
The biotin labeled, fragmented cDNA was added to the hybridization master mix.  
Table 4.4 describes the reagents utilized in this reaction.  The B2 control oligo acts as a 
hybridization control and allows for alignment of the GeneChip microarray in the 
analysis software.  Herring sperm DNA was used as a blocking agent during hybridization 
to prevent improper annealing of cDNA fragments with probes.  
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The E. coli Genome 2.0 Array (Affymetrix; Santa Clara, CA) was allowed to 
equilibrate to room temperature.  This GeneChip allows the detection of transcripts 
from E. coli K12 (MG1655) as well as a uropathogenic strain (CFT073) and two 
enterohemorrhagic strains of the serotype O157:H7 (EDL933 and Sakai).  200 µl of the 
hybridization solution was added to the GeneChip and the array was placed in the 
hybridization oven (Affymetrix; Santa Clara, CA) at 45˚C, 60 RPM for 16 hr.  The 
hybridization solution was then removed and replaced with 80 µl of non-stringent wash 
buffer (wash buffer A; 6x SSPE, 0.01% Tween-20) and the GeneChips were stored at 4˚C 
until washed and stained.   
GeneChip Washing, Staining, and Scanning 
The GeneChip Operating Software (GCOS; Affymetrix; Santa Clara, CA) controlled 
the operation of the Fluidics Station 450 (Affymetrix; Santa Clara, CA).  Streptavidin 
phycoerythrin (SAPE; Table 4.5) was loaded into the first and third 1.5 ml staining vial in 
the fluidics station, while the second stain vial contained an antibody solution mix (Table 
4.6).  The Mini_prok2v1_450 fluidics station protocol (Table 4.7) was followed for 
washing and staining hybridized biotin labeled cDNA fragments.  The GeneChip Scanner 
3000 (Affymetrix; Santa Clara, CA) and GCOS were used to produce .cel files which 
contained the fluorescence intensity data for a probe.  Each target sequence contains 11 
25-oligomer probes that are spread throughout the entire sequence (perfect match) as 
well as 11 25-oligomer probes that match the target with the exception of the 13th 
nucleotide which is a mismatch to the desired target sequence and indicates non-
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specific binding (mismatch).  Fluorescence data for these 22 probes are combined into a 
probe set for further analysis.   
Statistical Analysis of Microarray Data 
 The R programming environment (v 2.5.1) was used for all microarray data 
analysis.  First, GCOS generated CEL files, CDF file, and probe file were uploaded into the 
GCRMA package (v 2.0.0) (48).  This program normalizes microarray data by using 
Affymetrix probe sequence affinities based on the specific probe sequence in addition to 
normalization from background noise also used in robust multiarray average (RMA) 
analysis.  Following normalization with the GCRMA package, the intensities for probe 
sets were compared among treated and control cells across all time points using the 
microarray analysis of variance package (MAANOVA; v 1.4.1) (47). Next, the positive 
false discovery rate (pFDR; q-value) was determined to differentiate genes which were 
significantly regulated in response to exposure of sodium benzoate (q-value; v 1.10.0) 
(9).  A subset of genes which were differentially regulated (q < 0.05) were determined 
and used for further analysis. 
Selection of genes for validation with Real-time one-step reverse-
transcriptase PCR (rt-RT-PCR) 
    Three tools were used to analyze microarray results so a subset of significantly 
regulated genes could be selected for further validation with rt-RT-PCR.  The Pathway 
Tools Omics Viewer (SRI International; Menlo Park, CA) was used to visualize metabolic, 
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transport, and signaling pathways in addition to proteins integral to the membrane and 
periplasm specific to E. coli O157:H7 (36).  The output would link through pathway tools 
to BioCyc (SRI International; Menlo Park, CA) and give further insight to pathways, 
molecular interactions, proteins, and genes.  However, the database specific to E. coli 
O157:H7 was computationally generated with very little curation based on findings in 
current literature.  When the pathways of interest were homologous to E. coli K-12, the 
EcoCyc database which receives extensive literature based curation was utilized to gain 
further insight to functional and regulatory information for a pathway of interest (24).   
Selection of housekeeping genes for standardization of rt-RT-PCR  
Secondary validation of microarray data was achieved with the Pfaffl method which 
incorporates the efficiency of a PCR reaction in addition to the difference in Ct values 
between the treated and control samples (39).  The equation below shows how the 
ratio is calculated to determine increased or decreased levels of target mRNA when 
comparing the control and treated sample.  This difference is also standardized with one 
or more reference or housekeeping genes which are expressed at the same level 





From the microarray data, genes were selected which had a highly non-significant q-
value (q>0.98).  Genes were excluded if their function was not known, or if there was a 
high amount of variability between replicate microarrays.  rt-RT-PCR was used to 
validate these genes as appropriate housekeeping markers for microarray validation.  
Each sample was run in triplicate and there were a total of six cycle threshold values for 
each treatment within each time point.  A completely randomized design with repeated 
measures was used to assure there was no difference in cycle threshold values within 
each time point (p>0.05; SAS v9.1; Cary, NC).  This methodology helped to assure that 
there was no difference in mRNA expression between treatments.  
Nucleic acid amplification 
rt-RT-PCR was performed on RNA extracts as a means of microarray validation. 
SuperScript™ III Platinum® SYBR® green one-step rt-RT-PCR kit reagents (Invitrogen; 
Carlsbad, CA) were utilized in 25 µl reactions (2.5 µl serially-diluted RNA, 12.5 µl SYBR® 
green reaction mix, 1 µl BSA, and 0.5 µl SuperScript™ III reverse transcriptase/Platinum® 
Taq Mix, 0.025 µg forward and reverse primers for the target gene, and the remainder 
RNase-DNAse free water). Primer sequences (Table 4.8) were developed using Beacon 
Designer 4.0 software (Premier Biosoft International; Palo Alto, CA).  The Bio-Rad My 
iQ™ single color real-time PCR detection system (Hercules, CA) was used to conduct rt-
RT-PCR using the following parameters: 1) conversion of mRNA to cDNA, 35 min at 50˚C; 
2) denature reverse-transcriptase, 2 min at 94˚C; 3) denature template, 30 sec at 94˚C; 
annealing of primers, 45 sec at 55˚C; and extension with Taq polymerase, 30 sec at 72˚C; 
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repeated 40 times; 4) final extension, 5 min at 72˚C; 5) melt curve.  All rt-RT-PCR 
experiments were conducted in triplicate for each RNA sample and a negative control 
was included for each assay.  
Results and Discussion 
Microarray analysis revealed a large number of genes that were significantly 
regulated in response to 0.5% sodium benzoate.  As shown in Table 4.9, the number of 
genes which were differentially regulated increased with exposure time, and after 60 
minutes of exposure to sodium benzoate 1707 genes were found to be differentially 
expressed (q≤0.05). 
Ontology analysis allowed for insight to genes which responded to sodium 
benzoate exposure based on biological process, molecular functions, or cellular 
components.  Genes categorized into biological processes were the greatest to respond 
across all time points (Table 4.10).  There were a large number of genes associated with 
biological process nodes which responded quickly to sodium benzoate exposure (0 and 
5 min).  Most of these nodes were associated with metabolic activities such as protein 
biosynthesis.  Genes associated with the ribosome and RNA binding were also found for 
these early time point.  Genes involved in protein translation respond very early to the 
stimulus of sodium benzoate. 
 There was a rapid decline in significant ontology categories at 15 min, but an 
increase was observed for 30 and 60 min.  At 15 min the biological process nodes 
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represented genes that responded to unfolded proteins and alcohol metabolism.  
Significant cellular component nodes were found for genes involved with the cell 
membrane.  Genes were also found to be regulated that responded to the molecular 
functions of carbohydrate transport and nickel ion binding.   
Genes associated with molecular functions and cellular components had a 
greater response to sodium benzoate after 30 and 60 min of exposure.  Molecular 
function nodes which had increased expression at these time points pertained to RNA 
and ATP binding activity as well as carbohydrate transport.  The significant cellular 
component nodes at these times were oriented around the ribosome and products 
which were integral to the membrane or part of the inner membrane.  Biological 
process nodes associated with a response to chemical and antibiotic stimuli were found 
after 15 min of exposure and continued until 60 min.  Many of these genes are 
components of efflux pumps as well as transcription regulators, such as marA, the 
multiple antibiotic resistance regulon activator.   
Ontology analysis gives insight to expression of genes that are found in E. coli K-
12.  While there is large amount of overlap between the genomes of K-12 and O157:H7, 
genes specific to O157:H7, termed O-islands, may contribute to this pathogen’s ability 
to survive adverse environments as well as cause illness (38).  The urease operon was 
one such O-island which was found to have an increase in mRNA transcription when E. 
coli O157:H7 was exposed to sodium benzoate for 60 min.  This enzyme could give 
enterohemorrhagic E. coli (EHEC) the ability to neutralize acidic environments and allow 
for survival in acidic food products as well as support survival in the gastrointestinal 
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tract.  Therefore, further validation of the microarray results for the structural proteins 
of the urease operon with rt-RT-PCR were conucted.   
The glutamine synthetase adenyltransferase (glnE) gene catalyzes the addition of 
AMP to a subunit of glutamine synthetase. PspF is a σ54 dependent transcriptional 
activator that is cis-acting on the phage-shock protein (psp) operon and has been found 
to be constitutively expressed (20, 21).  No significant differences were found in Ct 
values for these genes across treatments within time points for either gene (p > 0.05).  
Therefore, glnE and pspF were utilized as the housekeeping genes by which rt-RT-PCR 
assays were normalized in the Pfaffl method.     
The log2 fold-change between 0.5% sodium benzoate treated E. coli O157:H7 
cells and that of the control conditions is shown in Table 4.11.  The structural genes of 
the urease operon (ureA,ureB, and ureC) were validated with rt-RT-PCR.  All structural 
genes had increased expression when cells were exposed to 0.5% sodium benzoate for 
60 min (Table 4.11).  Expression of ureA was slightly higher in the rt-RT-PCR analysis 
compared to the microarray data (3.1 versus 2.6 log2 fold-change, respectively).  
However, comparative fold-change values for ureB and ureC were slightly lower for the 
rt-RT-PCR analysis compared to those obtained from microarray analysis (Table 4.11).  
This indicates that the production of urease may increase in response to sodium 
benzoate since the transcription of the genes which compose the three subunits of the 
apourease enzyme are up-regulated.     
The accessory genes of the urease operon were not validated with rt-RT-PCR, but 
the fold-change values from microarray analysis are shown in Table 4.12.  They follow a 
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similar trend in expression to the structural genes of urease.  All accessory protein genes 
have a > 4-fold increase in transcription (linear scale), but like ureB and ureC,  these 
values may be slightly inflated in the microarray analysis. Urease is a nickel-containing 
enzyme that requires these accessory proteins to interact with the structural subunits 
UreA, UreB, and UreC.  The homologous proteins of Klebsiella aerogenes have been 
studied to determine the function of urease accessory proteins; UreD, UreF, and UreG 
interact with the structural subunits while UreE binds intracellular Ni2+ (8, 43, 44).  All 
accessory proteins interact to promote the transfer of nickel to the metallocenter of the 
enzyme which is necessary for urease activity (8, 19, 43, 44).   
It was noted when conducting analysis in the Omics Viewer that the nickel 
transporter proteins of E. coli O157:H7 were down-regulated in sodium benzoate 
treated cells (NikABCDE; Table 4.13).  However, this down-regulation was lessened with 
time and the activator of this protein, Fnr, was increased with exposure time (Table 
4.13).  Fnr is known to activate the nickel transporter operon in the absence of oxygen 
since nickel is required during anaerobic growth for NiFe-hydrogenase synthesis (41).  
However, both cultures were grown in a similar manner with shaking to increase culture 
aeration.  Therefore, this mechanism should not playing a large role in fnr transcription.  
Most likely, the increased transcription of fnr observed in this study is in response to cell 
need for nickel for adequate urease production.   
Since the production of functional urease by E. coli O157:H7 has been 
questioned in previous research (17, 19, 34, 35), the maintenance of an alkaline 
environment in urea broth and agar was studied for further validation of these findings.  
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First, cells were grown in LB with and without 0.5% sodium benzoate for 24 hr, after 
which they were surface plated onto urea agar.  E. coli O157:H7 on urea agar did not 
produce an alkaline reaction, indicating that urease was not produced under either of 
these conditions.  However, when stationary phase E. coli O157:H7 was inoculated into 
urea broth with and without 0.5% sodium benzoate for 24 hr, an alkaline environment 
was maintained in urea broth containing 0.5% sodium benzoate, and an acidic 
environment was produced in the control (Figure 4.1).  This indicates that E. coli 
O157:H7 responds rapidly to the stimulus when producing urease, and once this 
stimulus is removed urease is no longer produced.    
When examining fur expression in the microarray data, a slight increase in 
transcription was seen among all time points for sodium benzoate treated cells (data 
now shown); there was a 1.4-1.8 fold increase (linear scale) in transcription for fur.  This 
supports the findings that Fur can help stimulate production of urease, but there is also 
a secondary trans-acting factor that controls the regulation of this operon (19). 
This indicates that sodium benzoate allows E. coli O157:H7 to maintain an 
alkaline environment that is not achieved otherwise. This supports data from microarray 
and rt-RT-PCR results and indicates that increased transcription of urease mRNA 




These data support previous research that E. coli O157:H7 does not express 
urease constitutively, but requires stimulation of this operon from the environment. 
Exposure to sodium benzoate in a neutral pH (6.8) resulted in increased transcription of 
structural and accessory urease genes.  Analysis of urease production in urea broth 
confirmed that a functional enzyme was produced under these conditions that 
counteracted the effects of acid production in a culture system.   This indicates that 
research which concluded that urease genes were not functional due to lack of 
expression may have simply not been applying the appropriate stress to simulate 
expression of this enzyme.  Further research can focus on exposure to sodium benzoate 
followed by exposure to low pH and further examination of the resulting transcriptome 
with respect to adaptation mechanisms as well as virulence factors in EHEC.  Further 
studies will be focused on isolating urease structural proteins in sodium benzoate 
treated cells for further validation of this finding.   
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Table 4.1.  cDNA synthesis master mix components. 
Reagent Volume per reaction (µl) 
5X First-strand cDNA Buffer 12 
100 mM DDT 6 
10 mM dNTP Mix 3 
SUPERase-In (20 U/µl) 1.5 
Superscript II (200 U/µl) 7.5 




Table 4.2.  cDNA fragmentation master mix components. 
Reagent Volume per reaction (µl) 
10x One-Phor-All Buffer 2 
cDNA 15 
DNAse I 1.8 
Nuclease Free Water 1.2 
141 
 
Table 4.3.  Terminal labeling of cDNA fragments with biotin master mix components. 
Reagent Volume per reaction (µl) 
5x Reaction Buffer 10 
GeneChip DNA Labeling Reagent, 7.5mM 2 
Terminal Deoxynucleotidyl Transferase 2 
Nuclease Free Water 16 




















1 200 mMMES, 2M [Na+], 20 mM EDTA, 0.01% Tween-20 
Reagent Volume per reaction (µl) 
2x Hybirdization Buffer1 40 
3 nM B2 Control Oligo 1.3 
10 mg/ml Herring Sperm DNA 0.8 
50 mg/ml BSA 0.8 
100% DMSO 6.2 
Nuclease Free Water 5.9 
Fragmented and Labeled cDNA Product 25 
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Table 4.5.  Streptavidin phycoerythrin (SAPE) staining solution components. 
 
 
Reagent Volume per 
Reaction (µl) 
Final Concentration 
2x MES Stain Buffer 600 1x 
50 mg/ml BSA 48 2 mg/ml 
1 mg/ml Streptavidin 
Phycoerythrin 
12 10 µg/ml 
Nuclease Free Water 540  
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Table 4.6.  Antibody solution mix components. 




2x MES Stain Buffer 300 1x 
50 mg/ml BSA 24 2 mg/ml 
10 mg/ml Goat IgG 6 0.1 mg/ml 
0.5 mg/ml Anti-streptavidin Antibody (goat),  
Biotinylated 
6 5 µg/ml 
Nuclease Free Water 540  
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Table 4.7.  Mini_prok2v1_450 fluidics station program. 
Step Temperature (˚C) Description 
Post Hyb Wash #1 30 10 cycles of 2 mixes/cycle with Wash 
Buffer A 
Post Hyb Wash #2 50 4 cycles of 15 mixes/cycle with Wash 
Buffer B 
1st Stain 35 Stain the probe array for 5 min in SAPE 
2nd Stain 35 Stain the probe array for 5 min in 
Antibody Solution Mix 
3rd Stain 35 Stain the probe array for 5 min in SAPE 
Final Wash 35 15 cycles of 4 mixes/cycle with Wash 
Buffer A  
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Table 4. 8.  Primers for rt-RT-PCR assays to determine mRNA expression of ureA, ureB, 
ureC, glnE, and pspF in E. coli O157:H7 when exposed to 0 and 0.5% sodium benzoate. 
Primer Sequence (5′→3′) ProductTm (˚C) Product size (bp) 
ureAF CTTAACTATCCCGAATCC 86.5 138 
ureAR TTCTGGTATGCCTTCC   
ureBF GCAGTATTATCGTTGAAAATC 83.5 111 
ureBR AGCCTCTTGCCTTCTGG   
ureCF CGGGTTGCTGGGTAAAG 86.5 328 
ureCR CGGATTGGTTGAGGAAGG   
glnEF GGATGGCTTCGTCTATCG 88 361 
glnER GAGCTGGAACACCTGAAC   
pspFF TCTGCTGGATTCCGAACTG 86.5 226 




Table 4.9.  Number of differentially regulated genes over time (q<0.05) when E. coli 
O157:H7 is exposed to 0.5% sodium benzoate. 
Time  
(min) 











Table 4.10.  Number of significant ontology nodes within biological process, cellular 









0 51 8 11 5.1077E-4 
5 57 0 3 5.1851E-4 
15 4 2 6 1.0249E-4 
30 14 10 13 2.7975E-4 
60 32 15 26 6.3335E-4 
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Table 4. 11.  Increased transcription of ureA, ureB, and ureC mRNA (q<0.05) in E. coli 
O157:H7 when exposed to 0.5% sodium benzoate for 60 min and analyzed with high 




Microarray q-value rt-RT-PCR log2 
fold-change 
ureA 2.3 1.66 E-6 3.1 
ureB 2.0 8.41E-7 1.6 




Table 4. 12.  Increased transcription of ureD, ureE, ureF, and ureG mRNA in E. coli 
O157:H7 when exposed to 0.5% sodium benzoate for 60 min and analyzed with high 







ureD 2.5  1.92 E-6 
ureE 2.1  5.03 E-6 
ureF 2.5  3.65 E-6 
ureG 2.5  5.08 E-7 
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Table 4.13.  Transcription of nikA, nikB, nikC, nikD, nikE, nikR, and fnr mRNA in E. coli O157:H7 when exposed to 0.5% sodium 
benzoate and analyzed with high density oligonucleotide microarrays. 
 
















nikA -2.8 0.005 -4.3 0.001 -2.8 0.004 -0.5 0.0005 
nikB -2.0 0.003 -4.1 1.5E-5 -2.8 9.56E-5 -1.2 0.004 
nikC -2.3 0.005 -4.6 0.0001 -3.9 0.0003 -1.5 0.02 
nikD -2.1 0.001 -4.3 2.41E-5 -3.6 8.06E-5 -1.1 0.01 
nikE -1.9 0.0006 -3.2 1.61E-5 -2.9 4.77E-5 -1.3 0.003 
nikR -1.8 2.77E-5 -2.8 2.6E-6 -2.6 3.4E-6 -1.0 0.0004 
fnr 0.4 0.06 1.1 2.16E-5 1.6 5.6E-6 2.1 1.7E-6 
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Figure 4.1. Growth of E. coli O157:H7 in A) urea broth with B) 0.5% sodium benzoate and C) 0% 
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